A PARTIAL LIST OF MEDICAL JOURNAL ARTICLES · Web viewA PARTIAL LIST OF MEDICAL JOURNAL ARTICLES and articles from other scientific journals DEALING WITH THE DANGER OF VACCINES Hronological

A PARTIAL LIST OF MEDICAL JOURNAL ARTICLES

and articles from other scientific journals

DEALING WITH

THE DANGER OF VACCINES

Hronological list of articles (all the lists are works in progress)

1946

Fatal Anaphylactic Shock occurrence in identical twins following second injection of diphtheria toxoid and pertussis antigen. JAMA June 1946 [6pgs]

1956

Encephalopathy due to Influenza Vaccine. Warren, W.R. Archives of Internal Medicine, 1956; 97:803

1960

Is Universal Vaccination Against Pertussis Always Justified? J. Strom, British Medical Journal, October 22, 1960, p. 1184-1186.

1964

Encephalopathy following Influenza Immunization. Woods, C.A.; Ellison, G.W. J. Pediat., 1964; 65,5:745-8

1966

Peripheral neuropathy following tetanus toxoid administration. Blumstein GI, et al. JAMA. 1966 Nov 28;198(9):1030-1

1967

Multiple Sclerosis and Vaccinations. Miller, H.; Cendrowski, W.; Schapira, K. BMJ 1967;April 22: 210-3 Unusual reactions to tetanus toxoid. Fardon DF. JAMA. 1967 Jan 9;199(2):125-6. Excessive use of tetanus toxoid boosters. Edsall G, et al. JAMA. 1967 Oct 2;202(1):111-3. Side Reaction to Measles Vaccination Suggesting the Arthus Phenomenon. F. Buser. NEJM, 277(5), 1967,

p. 250-251.

Delayed Dermal Hypersensitivity Following Killed Measles Vaccine. Lennon & P. Isaacson. Journal of Pediatrics, 71(4), 1967, R.G. p. 525-529.

1

1968

Malignant Tumors as a Late Complication of Vaccination, Arch Derm Vol 98, 1968 [4pgs] Allergic reactions to tetanus toxoid. Steigman A. J Pediatr. 1968 Oct;73(4):648-9. Abuse of tetanus toxoid. Steigman AJ. J Pediatr. 1968 May;72(5):753-4.

1969

Side effects of tetanus toxoid. II. Antigenic materials derived from the constituents of the medium for toxoid preparation. Japanese. Akama K, et al. Nippon Saikingaku Zasshi. 1969 Nov;24(11):595-601.

Paralysis of the recurrent laryngeal nerve following a booster injection of tetanus toxoid. German. Eicher W, et al. Munch Med Wochenschr. 1969 Aug 22;111(34):1692-5.

Encephalitis after measles vaccination. Barbor PR, et al. Lancet. 1969 Jul 5;2(7610):55-6. Allergic reactions against anti-tetanus toxoid. Italian. Dal Bo S. Folia Allergol (Roma). 1969 Jan-

Feb;16(1):63-73. Transient Arthritis after Rubella Vaccination. L.Z. Cooper, et al. American Journal Dis Child, 118, 1969, p.

218-225.

1970

Two Syndromes Following Rubella Immunization. A.W. Kilroy, et al. JAMA, 214(13), 1970, p. 2287-2292.

1971

Accommodation paresis and swallowing paralysis following tetanus toxoid booster inoculation. German.Harrer G, et al. Wien Med Wochenschr. 1971 Apr 10;121(15):296-7.

1972

Mumps vaccine and nerve deafness. Healy CE. Am J Dis Child. 1972 Jun;123(6):612. Atypical measles in children previously immunized with attenuated measles virus vaccines. Cherry JD, et al.

Pediatrics. 1972 Nov;50(5):712-7.

Atypical measles. Severe illness in recipients of killed measles virus vaccine upon exposure to natural infection. Brodsky AL. JAMA. 1972 Dec 11;222(11):1415-6.

Relapsing Encephalomyelitis Following the Use of Influenza Vaccine. Yahr, M.D, et al. Arch Neurol, 1972; Aug, 27:182-3

Rubella Vaccine Myecloradiculoneuritis. R.C. Gilmartin, et al. Journal of Pediatrics, 80(3), 1972, p. 406-412.

Recurrent Joint Symptoms in Children Vaccinate with HPV-77DK12 Rubella Vaccine. S.L. Spruance, et al. Journal of Pediatrics, 80(3), 1972, 413-417.

1973

Thrombotic thrombocytopenic purpura after influenza vaccination. Brown RC, et al. Br Med J. 1973 May 5;2(861):303.

Guillain-Barre syndrome. Occurrence following combined mumps-rubella vaccine. Gunderman JR. Am J Dis Child. 1973 Jun;125(6):834-5.

Anaphylactic reaction following injection of tetanus toxoid. German. Ehrengut W, et al. Dtsch Med Wochenschr. 1973 Mar 9;98(10):517.

Adverse reactions to tetanus toxoid. Rose I. Lancet. 1973 Feb 17;1(7799):380. Hypersensitivity to tetanus toxoid. Facktor MA, et al. J Allergy Clin Immunol. 1973 Jul;52(1):1-12. Neurologic Disorders Following Live Measles-Virus Vaccination. P.J. Landrigan & J.J. Witte. JAMA, 223(13),

1973, p. 1459-1462.

Hazard of influenza vaccine in neurologic patients. Rabin J. JAMA. 1973 Jul 2;225(1):63-4.

2

Failure of Rubella Herd Immunity During an Epidemic. L.E. Klock & G.S. Rachelefsky. NEJM, 288(2), 1973, p. 69-72.

1974

Influenza infections during pregnancy: association with congenital malformations and with subsequent neoplasms in children, and potential hazards of live virus vaccines. MacKenzie JS, et al. Bacteriol Rev. 1974 Dec;38(4):356-70. Review.

Letter: Hypersensitivity to tetanus toxoid. Michels MI, et al. J Allergy Clin Immunol. 1974 Feb;53(2):118-9. Letter: Acute reaction following injection with tetanus toxoid. German. Fischmeister M. Dtsch Med

Wochenschr. 1974 Apr 19;99(16):850. Severe Complication of Measles Vaccination. Modern Medicine of Australia, January 7, 1974, p.60.

1975

Letter: Diabetes mellitus after mumps vaccination. Sinaniotis CA, et al. Arch Dis Child. 1975 Sep;50(9):749-50.

Anaphylactic shock due to tetanus toxoid. Hebrew. Chanukoglu A, et al. Harefuah. 1975 Nov 16;89(10):456-7.

Is mumps virus an etiologic factor in juvenile diabetes mellitus? Sultz HA, et al. J Pediatr. 1975 Apr;86(4):654-6.

1976

Sudden Death Amoung Finnish Conscripts (this deals with vaccines causing death due to damage to heart) British Med J 1976 [3pgs]

Tetanus toxoid hypersensitivity. Vellayappan K, et al. J Singapore Paediatr Soc. 1976 Apr;18(1):17-9. Diffuse myelitis associated with rubella vaccination. Holt S, et al. Br Med J 1976 Oct 30;2(6043):1037-8 –

(This article presents the cases of two women who developed diffuse myelitis shortly after receiving rubella vaccination. Neither patient fully recovered her motor function.)

Guillain-Barre syndrome following administration of live measles vaccine. Grose C, et al. Am J Med. 1976 Mar;60(3):441-3.

Neurologic diseases following influenza vaccination. German. Saito H, et al. Med Welt. 1976 May 7;27(19):912-4.

Paralysis after tetanus prevention. French. Gersbach P, et al. Schweiz Med Wochenschr. 1976 Jan 31;106(5):150-3.

Abnormalities of cellular immune response in arthritis induced by rubella vaccination. Chiba Y, et al. J Immunol 1976 Nov;117(5 Pt 1):1684-7 – (This study discusses the cases of 15 children who developed arthralgia or arthritis after vaccination with the live attenuated rubella vaccine. All patients showed profound depression of cellular immune response to the rubella virus.)

Measles in Adults: An Unforeseen Consequence of Immunization? K.H. Rand, et al. JAMA, 235, 1976, p. 1028-1031.

Exaggerated natural measles following attenuated virus immunization. St Geme JW Jr, et al. Pediatrics 1976 Jan;57(1):148-9

1977

A case of algodystrophic syndrome of the upper limb following tetanus vaccination. French. Bensasson M, et al. Sem Hop. 1977 Oct 23;53(36):1965-6.

Neurological complications after influenza vaccination. German. Ehrengut W, et al. MMW Munch Med Wochenschr. 1977 May 20;119(20):705-10.

Late vaccination complications in the prevention of tetanus and rabies. German. Pataky L. Z Gesamte Hyg. 1977 Dec;23(12):917-8.

Diffuse myelitis associated with rubella vaccination. Behan PO. Br Med J. 1977 Jan 15;1(6054):166. Unusual neurological complications following tetanus toxoid administration. Schlenska GK. J Neurol. 1977

Jul 20;215(4):299-302.

3

Complications of pertussis immunization. German Lenard HG, et al. Monatsschr Kinderheilkd 1977 Jun;125(6):660-7

1978

Neurologic disorders following tetanus vaccination. A case report. Dieckhofer K, et al. Med Welt. 1978 Nov 3;29(44):1710-2.

Optic neuritis complicating measles, mumps, and rubella vaccination. Kazarian EL, et al. Am J Ophthalmol 1978 Oct;86(4):544-7

Neurologic affections after influenza inoculation. German. Saito H, et al.Nervenarzt. 1978 Feb;49(2):90-6. Anaphylactic reaction following subcutaneous administration of tetanus anatoxin. Russian. Bilyk MA, et al.

Klin Med (Mosk). 1978 Sep;56(9):137-8.

1979

DTP Vaccination and Sudden Infant Deaths, Tennessee MMWR March 23,1979 [2pgs] Neurological complications following measles vaccination. Allerdist H. Dev Biol Stand 1979;43:259-

64 Local reactions after repeated tetanus vaccinations. German. Wegmann A, et al. Schweiz Med Wochenschr.

1979 Oct 6;109(38):1409-10. Peripheral neuropathy after administration of tetanus toxoid. Baust W, et al. J Neurol. 1979;222(2):131-33.

1980

Fatal Guillain-Barre syndrome after the national influenza immunization program. Keenlyside RA, et al. Neurology 1980 Sep;30(9):929-33

Acute disseminated encephalomyelitis after influenza vaccination. Saito H, et al. Arch Neurol. 1980 Sep;37(9):564-6. – (This article reports on the case of a 12-year-old previously healthy boy who developed acute disseminated encephalomyelitis four days after influenza vaccination.)

Adverse reactions following tetanus toxoid injection. Mandal GS, et al. J Indian Med Assoc. 1980 Jan 16;74(2):35-7.

1981

Neurological complication after vaccination by tetanic anatoxin. Slovak. Farbaky M. Cesk Epidemiol Mikrobiol Imunol. 1981 Jan;30(1):10-2.

Recurrent pericarditis: a rare complication of influenza vaccination. Streifler JJ, et al. Br Med J (Clin Res Ed). 1981 Aug 22;283(6290):526-7.

Reactivation of vasculitis after influenza vaccination. Cannata J, et al. Br Med J (Clin Res Ed). 1981 Aug 22;283(6290):526.

Guillain-Barré syndrome and the 1978-1979 influenza vaccine. Hurwitz ES, et al N Engl J Med 1981;304:1557-61.

Unusual reaction to tetanus toxoid. Robinson IG. N Z Med J. 1981 Nov 11;94(695):359. Pneumococcal Vaccine Failures. Two Case Reports and Reviews, C.V. Sumaya, et al., American Journal Dis

Children, 135(2), 1981

1982

Peripheral neuropathy after multiple tetanus toxoid injections. Reinstein L, et al. Arch Phys Med Rehabil 1982 Jul;63(7):332-4 - (This article presents the case of a 33-year-old man who developed severe peripheral neuropathy and segmental demyelination after receiving two tetanus immunizations during a 5-month period. Recovery was only partial. This is the fourteenth such case reported in the literature.

Influenza vaccine and dermatomyositis. Winkelmann RK. Lancet. 1982 Aug 28;2(8296):495 Bilateral optic nerve atrophy and blindness following swine influenza vaccination. Brown RC, et al. Ann

Ophthalmol. 1982 Apr;14(4):398-9. Optic neuritis and myelitis following rubella vaccination. Kline LB, et al. Arch Neurol. 1982 Jul;39(7):443-4. Anaphylactic reaction to tetanus toxoid. Wiseman TL Ann Allergy. 1982 Nov;49(5):308. Guillain-Barré syndrome in the U.S. Army. Roscelli J.D., et al. Arch Neurol 1982;39:21-24. Guillain-Barré Syndrome in the United States, 1979-1980 and 1980-1981. Kaplan JE, et al. JAMA

1982;248:698-700

4

Life-threatening anaphylactic reaction to tetanus toxoid. Zaloga GP, et al. Ann Allergy. 1982 Aug;49(2):107-8.

Diphtheria-pertussis-tetanus (DPT) immunization: a potential cause of the Sudden Infant Death Syndrome (SIDS). Torch, W.S., 1982. Neurology; 32(4): A169.

1983

Neurologic complications of tetanus toxoid. Fenichel GM. Arch Neurol. 1983 Jun;40(6):390. Measles vaccine associated encephalitis in Canada. White F. Lancet. 1983 Sep 17;2(8351):683-4. Neurologic complications of tetanus toxoid. Holliday PL, et al. Arch Neurol. 1983 Oct;40(10):659. Convulsions after measles immunization. Berlin, BS. Lancet 1983 Jun 18;1(8338):1380. Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids. Holliday PL, et al. Arch

Neurol. 1983 Jan;40(1):56-7. Reactions to tetanus toxoid. Graham DR. JAMA. 1983 Sep 9;250(10):1273-4. Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant

death syndrome. Baraff LJ, et al. Pediatr Infect Dis 1983 Jan-Feb;2(1):7-11

Seizures Following Childhood Immunizations. D.G. Hirtz, et al. Journal of Pediatrics, 102(12), 1983, p. 14-18.

1984

Recurrent Seizures After Diphtheria, Tetanus, and Pertussis Vaccine Immunization, AJDC Oct 1984 Vol 138[3pgs]

Abnormal T- Lymphocyte Subpopulations in Healthy Subjects After Tetanus Booster Immunization New England Journal of Medicine Jan 1984 [2pgs]

Abnormal T- Lymphocyte Subpopulations in Healthy Subjects After Tetanus Booster Immunization New England Journal of Medicine Jan 1984 [2pgs]

Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I. Otten A, et al. Behring Inst Mitt. 1984 Jul;(75):83-8.

Neuralgic amyotrophy after administration of tetanus toxoid. Kiwit JC. J Neurol Neurosurg Psychiatry. 1984 Mar;47(3):320

An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. Langmuir AD, et al. Am J Epidemiol. 1984 Jun;119(6):841-79.

1985

Sensorineural hearing loss following live measles virus vaccination. Brodsky L, et al. Int J Pediatr Otorhinolaryngol. 1985 Nov;10(2):159-63.

Neurologic syndromes as atypical courses of vaccination following preventive influenza A vaccination. Saito H, et al. Z Gesamte Hyg. 1985 Apr;31(4):218-20. German.

Herpes zoster following varicella vaccine in a child with acute lymphocytic leukemia. Williams DL, et al. J Pediatr. 1985 Feb;106(2):259-61

Diffuse retinopathy following measles, mumps, and rubella vaccination. Marshall GS, et al. Pediatrics. 1985 Dec;76(6):989-91.

Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. Tingle AJ, et al. J Infect Dis 1985 Sep;152(3):606-12 – (This article reports on the cases of six women who developed arthritis in several joints 12 days to three weeks after rubella immunization. Symptoms persisted in all women over a 2- to 7-year period, and were accompanied by acute neurological manifestations such as carpal tunnel syndrome or multiple paresthesiae (feelings of numbness or tingling) in three women and recurrent episodes of blurred vision, paresthesiae, and painful limb syndromes in two women.)

1986

Neurologic Complications In Oral Polio Vaccine Recipients, Journal of Ped, June 1986 [4pgs] Thrombocytopenic purpura following varicella-zoster vaccination. Lee SY, et al.

Am J Pediatr Hematol Oncol 1986 Spring;8(1):78-80 – (This article reports on

5

the case of a child with leukemia who developed acute thrombocytopenia (a blood disorder) 3 weeks after exposure to varicella-zoster vaccine.)

Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Helmke K, et al. Diabetologia. 1986 Jan;29(1):30-3.

Systemic reactions during cutaneous testing for tetanus toxoid hypersensitivity. Mansfield LE, et al. Ann Allergy. 1986 Aug;57(2):135-7.

Outbreak of Paralytic Poliomyelitis in Finland: Widespread Circulation of Antigenically Altered Poliovirus Type 3 in a Vaccinated Population, T. Hovi, et al., Lancet, 1(8495), June 21, 1986, p. 1427-1432.

Characteristics of diphtheria-pertussis-tetanus (DPT) postvaccinal deaths and DPT-caused Sudden Infant Deaths Syndrome (SIDS): a review. Torch, W.C., 1986. Neurology (suppl 1); 36: 148.

Injections and poliomyelitis: what are the risks of vaccine associated paralysis? Wyatt HV. Dev Biol Stand 1986;65:123-6

1987

Guillain-Barre syndrome after vaccination with purified tetanus toxoid. Newton N Jr, et al. South Med J 1987 Aug;80(8):1053-4

Asthma and urticaria after hepatitis B vaccination. Lohiya G. West J Med. 1987 Sep;147(3):341.

Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. Gelb LD, et al. J Infect Dis 1987 Apr;155(4):633-40 – (This article notes that rashes occurring during the initial six weeks after vaccination are invariably caused by the vaccine virus. Furthermore, true breakthrough varicella (caused by the wild-type virus) can still develop in vaccinated individuals. The authors describe five cases of zoster occurring in vaccinated leukemic children in remission. One case, in which the causative virus was identified as the vaccine strain, occurred 22 months after vaccination, demonstrating the capability of the live, attenuated vaccine virus to remain latent and be reactivated at a later time.)

Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Brunell PA, et al. Pediatrics 1987 Jun;79(6):922-7 – (This article reports on the cases of 5 out of 52 children with acute lymphocytic leukemia in which chickenpox occurred after administration of the live varicella vaccine.)

Complications after specific prevention of tetanus. Russian. Korableva NN, et al. Khirurgiia (Mosk). 1987 Jan;(1):90-3.

Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella. Azeemuddin S. Clin Pediatr (Phila). 1987 Jun;26(6):318.

Diptheria-Tetanus-Pertussis Immunization and Sudden Infant Death Syndrome, A. Walker, American Journal of Public Health, 77(8), 1987, p. 945-951.

Measles Outbreak in a Fully Immunized Secondary-School Population. T.L. Gustafson, et al. NEJM, 316(13), 1987, p. 771-774.

1988

Erythema multiforme following diphtheria and tetanus toxoid vaccination. Griffith RD, et al. J Am Acad Dermatol. 1988 Oct;19(4):758-9.

Polyneuropathies following administration of tetanus toxoid. Grond M, et al. Nervenarzt. 1988 May;59(5):309-12.

Myasthenia gravis after general anesthesia and hepatitis B vaccine. Biron P, et al. Arch Intern Med. 1988 Dec;148(12):2685.

Acute midbrain syndrome as an adverse reaction to tetanus immunization. Schwarz G, et al. Intensive Care Med 1988;15(1):53-4

Unilateral deafness as a complication of the mumps, measles, and rubella vaccination. Nabe-Nielsen J, et al. BMJ. 1988 Aug 13;297(6646):489.

Rheumatoid purpura following influenza vaccination. Wattiaux MJ, et al Presse Med. 1988 Apr 9;17(13):649-50. French.

6

Is RA27/3 rubella immunization a cause of chronic fatigue? Allen AD. Med Hypotheses 1988 Nov;27(3):217-20 – (This article proposes a possible role of vaccination with the live rubella RA27/3 vaccine strain as a cause of chronic fatigue syndrome. Individuals with chronic fatigue syndrome (mainly women) have high levels of blood antibodies to several common viruses, but only rubella antibodies are positively correlated with the intensity of symptoms. Women are especially susceptible to developing such a condition after exposure to attenuated rubella vaccine. Within 3 years of introduction of the new, more potent strain of live rubella vaccine (strain RA27/3), cases of chronic fatigue began emerging in the literature. Considering all this, the possible role of rubella vaccination in the etiology of chronic fatigue syndrome should be considered.)

Mortality and Morbidity from Invasive Bacterial Infections During a Clinical Trial of Acellular Pertussis Vaccine in Sweden. J. Storsaeter, et al. Pediatric Infectious Disease Journal, 7(9), 1988, p. 637-645.

Efficacy of Haemophilus b Polysaccharide Vaccine: An Enigma. E.A. Mortimer. JAMA, 260(10), 1988, p. 1454-1455.

Spectrum of disease due to Haemophilus influenzae type b occurring in vaccinated children. Hiner EE, et al. J Infect Dis 1988 Aug;158(2):343-8

1989

Neurological complications after simultaneous immunization against tick-borne encephalitis and tetanus. Schabet M, et al. Lancet. 1989 Apr 29;1(8644):959-60.

Selective antibody deficiency to Haemophilus influenzae type B capsular polysaccharide vaccination in children with recurrent respiratory tract infection. Herrod HG, et al. J Clin Immunol 1989 Sep;9(5):429-34

Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barre syndrome) after immunization with Haemophilus influenzae type b conjugate vaccine. D'Cruz OF, et al. J Pediatr. 1989 Nov;115(5 Pt 1):743-6.

Aseptic meningitis after vaccination against measles and mumps. Cizman M, et al. Pediatr Infect Dis J. 1989 May;8(5):302-8.

Zoster in normal children after varicella vaccine. Plotkin SA, et al. J Infect Dis. 1989 May;159(5):1000-1. Herpes zoster in an adult recipient of live attenuated varicella vaccine. Hammerschlag MR, et al. J Infect Dis

1989 Sep;160(3):535-7 – (This article reports on the case of a healthy 30-year-old female physician who developed a localized case of herpes zoster 3 years after being immunized with two doses of live attenuated varicella vaccine.)

Mumps Meningitis Following Measles, Mumps and Rubella Immunisation. J.A. Gray & S.M. Burns, Lancet, 2, 1989

Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program. Halperin SA, et al. J Pediatr 1989 Nov;115(5 Pt 1):686-93

Cluster of childhood Guillain-Barre cases after an oral poliovaccine campaign. Uhari M, et al. Lancet 1989 Aug 19;2(8660):440-1

1990

Reactive arthritis after hepatitis B vaccination. Hachulla E, et al. J Rheumatol. 1990 Sep;17(9):1250-1. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. Rogerson SJ, et al. BMJ. 1990

Aug 11;301(6747):345.

Tetanus toxoid allergy. Weisse ME, et al. JAMA. 1990 Nov 14;264(18):2448.

Disease Caused by Haemophilus Influenza Type b in the Immediate Period after Homologous Immunization: Immunologic Investigation. S.K. Sood and R.S. Daum, Pediatrics, 1990

Evaluation of adverse events after influenza vaccination in hospital personnel. Scheifele DW, et al. CMAJ 1990 Jan 15;142(2):127-30)

Compensation Under the National Childhood Vaccine Injury Act. E.W. Clayton & G.B. Hickson. Journal of Pediatrics, 116(4), April 1990, p. 508-513.

1991

7

Child Mortality After High-Titre Measles Vaccines (this is on E-Z measles), Lancet Vol 338, 1991 [4pgs] A Prefecture-wide Survey of Mumps Meningitis Associated with Measles, Mumps and Rubella Vaccine,

(Infec Dis J 1991 Vol 10 pg 204-209) Herroelen L, et al. Central-nervous-system demyelination after immunisation with recombinant hepatitis B

vaccine. Lancet. 1991 Nov 9;338(8776):1174-5. - (This article reports on two cases of central-nervous-system demyelinating disease occurring six weeks after administration of recombinant hepatitis B vaccine. One patient had a history of multiple sclerosis while the other had no history of neurological disease.)

Mumps vaccination and type-I diabetes. German. Pawlowski B, et al. Dtsch Med Wochenschr. 1991 Apr 19;116(16):635.

Bilateral acute profound deafness after MMR vaccination--report of a case. Koga K, et al. Nippon Jibiinkoka Gakkai Kaiho. 1991 Aug;94(8):1142-5. Japanese.

Guillain-Barré syndrome and influenza vaccination in the U.S. Army, 1980-1988. Roscelli J.D., et al. Am J Epidemiol 1991;133:952-55.

Post-vaccinal hemi-convulsion hemiplegia syndrome. Article in French. Pladys P, et al. Ann Pediatr (Paris) 1991 Nov;38(9):602-4 – (This article reports the case of an 18-month-old infant who developed convulsions and paralysis in one side of the body after receiving a booster dose of DPT and polio vaccine.)

Aseptic meningitis as a complication of mumps vaccination. Sugiura A, et al. Pediatr Infect Dis J 1991 Mar;10(3):209-13 – (This article describes 311 suspected cases of vaccine-related meningitis occurring among 630,157 recipients of MMR vaccine in Japan.)

Pancreatitis caused by measles, mumps, and rubella vaccine. Adler JB. Pancreas. 1991 Jul;6(4):489-90. Tetanus toxoid anaphylaxis. Lleonart-Bellfill R, et al. DICP. 1991 Jul-Aug;25(7-8):870 Bilateral hearing loss after measles and rubella vaccination in an adult. Hulbert TV, et al. N Engl J Med. 1991

Jul 11;325(2):134 Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees

and household contact. Shiraki K, et al. J Med Virol 1991 Feb;33(2):128-32 – (This article discusses three cases of varicella occurring at varying intervals after vaccination. Two of the individuals had acute lymphocytic leukemia.)

A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine.Fujinaga T, et al. Pediatr Infect Dis J 1991 Mar;10(3):204-9 – (Reported here are 35 cases of meningitis, 6 cases of convulsive disorders, and 2 cases of parotitis occurring after MMR vaccination during an 8-month period following the introduction of a new MMR vaccine in Japan.)

Child mortality after high-titre measles vaccines: prospective study in Senegal. Garenne M, et al. Lancet 1991 Oct 12;338(8772):903-7

Outbreak of Paralytic Poliomyelitis in Oman: Evidence for Widespread Transmission Among Fully Vaccinated Children. R.W. Sutter, et al. Lancet, 338(8769), September 21, 1991, p. 715-720

Haemophilus B Disease after Vaccination with Haemophilus B Polysaccharide or Conjugate Vaccine. American Journal of Diseases of Children, 145(12), December 1991, p. 1379-1382

Mumps outbreak in a highly vaccinated population. Hersh BS, et al. J Pediatr 1991 Aug;119(2):187-93

1992

Chronic Arthritis After Rubella Vaccination, Clinical Infec Dis. 1992 15;307-12 [6pgs] Acute transverse myelitis after tetanus toxoid vaccination. Read SJ, et al. Lancet. 1992 May

2;339(8801):1111-2. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Topaloglu H, et al. Lancet. 1992 Jan

18;339(8786):178-9 Neurological complication following tetanus toxoid immunization. A case report. Olutade BO, et al. West Afr J

Med 1992 Jul-Sep;11(3):221-2 Varicella vaccine: the American experience. Gershon AA, et al. J Infect Dis 1992 Aug;166 Suppl 1:S63-8 –

(This review article notes that 50 percent of leukemic children experience mild to moderate adverse effects following exposure to live attenuated varicella vaccine. The authors add that adults have a lower degree of protection (70 percent) compared to children.)

Effect of measles-mumps-rubella vaccination on polymorphonuclear neutrophil functions in children. Toraldo R, et al. Acta Paediatr 1992 Nov;81(11):887-90 – (This study shows that administration of the MMR vaccine suppresses immune response in vaccine recipients. All children who received the vaccine showed reduced function of polymorphonuclear neutrophils (a type of white blood cell that plays a fundamental role in fighting infections) on the seventh day after immunization.

Investigation of a possible association between influenza vaccination and Guillain-Barre Syndrome in the United States, 1990-91. Chen R, et al. Post Marketing Surveillance 1992; 6:506.

Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine. Benjamin CM, et al. BMJ 1992 Apr 25;304(6834):1075-8 – (This study shows that children receiving the MMR vaccine

8

before age 5 are 12 times more likely to develop joint and limb symptoms compared to children who have not yet received the vaccine.)

Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. Sutter RW, et al. J Infect Dis 1992 Mar;165(3):444-9

Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine. - Howson CP, et al. JAMA 1992 Jan 15;267(3):392-6 ).

Severe tetanus in immunized patients with high anti-tetanus titers. Crone NE, et al. Neurology 1992 Apr;42(4):761-4

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Strebel P, et al. Clin Infect Dis 14:568-579, 1992.

Unnecessary injections and paralytic poliomyelitis in India. Wyatt HV, et al. Trans R Soc Trop Med Hyg 1992 Sep-Oct;86(5):546-9

1993

More on Vaccine Associated Paralytic Poliomyelitis, New England Journal of Medicine, Dec 23,1993 [2pgs] Reports of Sensorineural deafness after measles, mumps, and rubella immunization, Arch of Disease in

Childhood 1993:69 [2pgs.] Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Miller E, et al. Lancet

1993 Apr 17;341(8851):979-82 - (This study established via laboratory confirmation of viral meningitis that the true risk of aseptic meningitis following MMR vaccination is about 1 in 11,000 doses, substantially higher than the 4 per million estimated on the basis of pediatricians’ case reports.)

Acute myelitis after vaccination against hepatitis B. Mahassin F, et al. Presse Med 1993 Dec 18;22(40):1997-8 French.

Transverse myelitis following hepatitis B vaccination. Trevisani F, et al. J Hepatol. 1993 Sep;19(2):317-8. The possible relation between hepatitis B vaccination and chronic fatigue syndrome. Delage G, et al. Union

Med Can. 1993 Jul-Aug;122(4):278-9. French Serious hepatitis B vaccine adverse reactions: are they immune-mediated? Carmeli Y, De-Medina T.

Vaccine 1993 Oct;11(13):1358-9 Chronic rubella vaccine-associated arthropathy. Mitchell LA, et al. Arch Intern Med 1993 Oct

11;153(19):2268-74 – (This article reports on the cases of two women who, following rubella immunization, developed polyarthralgia, arthritis, rash, fever, paresthesia (numbness or tingling), and malaise lasting longer than two years after vaccination. The rubella virus was shown to replicate in the white blood cells of both patients.)

Haemophilus influenzae type B (HiB) meningitis in a 14-month-old child despite two vaccinations with HiB conjugate vaccine (PRP-D). German. Muntean W, et al. Wien Klin Wochenschr. 1993;105(18):523-6.

Visual loss and eosinophilia after recombinant hepatitis B vaccine. Brezin A, et al. Lancet. 1993 Aug 28;342(8870):563-4.

Severe systemic vasculitic syndrome post influenza vaccination. Gavaghan T, et al. Aust N Z J Med. 1993 Apr;23(2):220.

Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. Mader R, et al. J Rheumatol. 1993 Aug;20(8):1429-31. Review.

Delirium following influenza vaccination. Brown RC, et al. Am J Psychiatry. 1993 Dec;150(12):1899. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising

incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Hyoty H, et al. Diabetologia 1993 Dec;36(12):1303-8 – (This study shows that after introduction of nationwide MMR vaccination in Finland in 1982, the incidence of Type 1 diabetes in 0-14-year-old children increased until 1987. In 1988-1990 the incidence continued to rise in children up to 4 years old.)

Report of the working group on the possible relationship between hepatitis B vaccination and the chronic fatigue syndrome. CMAJ. 1993 Aug 1;149(3):314-9

Probable post-hepatitis A vaccination encephalopathy. Hughes PJ, et al. Lancet. 1993 Jul 31;342(8866):302.

Hepatitis B vaccine side-effect. Carmeli Y, Oren R Lancet 1993 Jan 23;341(8839):250-1 Multiple sclerosis and hepatitis B vaccination. Nadler JP. Clin Infect Dis. 1993 Nov;17(5):928-9 Varicella infection complicated with meningitis after immunization. Naruse H, et al. Acta Paediatr Jpn 1993

Aug;35(4):345-7

9

Guillain-Barre syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine. Gervaix A, et al. Eur J Pediatr 1993 Jul;152(7):613-4

Hemiplegia after measles, mumps, and rubella vaccination. Sackey AH, et al. BMJ. 1993 May 1;306(6886):1169.

Benign acute pericarditis after vaccination against hepatitis B. Bensaid J, et al. Presse Med. 1993 Feb 20;22(6):269. French.

Pancreatitis following vaccination against measles, mumps, and rubella in a young adult. Ramis Pedromingo M, et al. Aten Primaria. 1993 Feb 1;11(2):105. Spanish.

Reports of sensorineural deafness after measles, mumps, and rubella immunisation. Stewart BJ, et al. Arch Dis Child. 1993 Jul;69(1):153-4.

Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Nieminen U, et al. Acta Paediatr. 1993 Mar;82(3):267-70. – (This article reports 23 cases of acute thrombocytopenic purpura (a bleeding disorder marked by bruises) following MMR vaccination, which were seemingly due to auto-immune reactions induced by the vaccine.)

Secondary Measles Vaccine Failure in Healthcare Workers Exposed to Infected Patients. Infection Control & Hospital Epidemiology, 14(2), February 1993, p. 81-86.

Influenza epidemic among a community of elderly people in spite of vaccination. Dindinaud G, et al. Eur J Epidemiol 1993 Nov;9(6):667-70

1994

Vaccine Associated Poliomyelitis, Lancet Vol 343 [3pgs], March 1994 Pertussis Vaccination and Asthma: is there a link?, JAMA 1994 Vol 272 no 8 [1pg] Acute radiculomyelitis after antitetanus vaccination.Tezzon F, et al. Ital J Neurol Sci. 1994 May;15(4):191-3.

Review. Haemophilus influenzae type b meningitis after three doses of vaccine. Mulholland EK, et al. Lancet. 1994

Mar 26;343(8900):794. HiB meningitis immediately after vaccination. Hanna J. Med J Aust. 1994 Apr 4;160(7):452. A case of reactive arthritis after influenza vaccination. Streifler JJ, et al. Clin Rheumatol. 1994 Dec;13(4):645. Haemophilus B conjugate vaccination failure. Scheifele D, et al. Can Commun Dis Rep. 1994 Mar

15;20(5):37-9.Hepatitis B immunisation and reactive arthritis. Birley HD, et al. BMJ 1994 Dec 3;309(6967):1514

Hepatitis B immunisation and reactive arthritis. Birley HD, et al. BMJ 1994 Dec 3;309(6967):1514 Thrombocytopenic purpura after recombinant hepatitis B vaccine. Poullin P, et al. Lancet. 1994 Nov

5;344(8932):1293. Reiter's syndrome and reactive arthritis in health care workers after vaccination. Hassan W, et al. BMJ 1994

Jul 9;309(6947):94 Reiter's syndrome attributed to hepatitis B immunization. Fraser PA, et al. BMJ 1994 Dec 3;309(6967):1513 Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. Vautier G, et al. Br J

Rheumatol 1994 Oct;33(10):991 Rheumatic complications of influenza vaccination. Streifler JJ, et al. Aust N Z J Med. 1994 Oct;24(5):572-

3. Guillain-Barre syndrome after measles, mumps, and rubella vaccine. Morris K, et al. Lancet. 1994 Jan

1;343(8888):60. Guillain-Barre syndrome after measles, mumps, and rubella vaccine. Rees J, et al. Lancet. 1994 Mar

19;343(8899):733. Deisenhammer F, et al. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta

Neurol Scand. 1994 Jun;89(6):462-3. – (This article reports on the case of a woman who developed acute cerebellar ataxia 10 days after the second vaccination with recombinant hepatitis B vaccine.)

Hemophilus influenzae meningitis despite vaccination. Hebrew. Jurgenson U, et al. Harefuah 1994 Oct;127(7-8):231-4, 287

Influenza vaccine and dermatomyositis. Jani FM, et al. Vaccine. 1994 Nov;12(15):1484. Adverse reactions to tetanus toxoid. Sutter RW. JAMA. 1994 May 25;271(20):1629. Development of uveitis following vaccination for influenza. Brown RC, et al. Clin Infect Dis. 1994

Nov;19(5):979. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the

United States. Halloran ME, et al. Am J Epidemiol 1994 Jul 15;140(2):81-104 – (This article acknowledges that routine varicella immunization of children and adolescents "resulted in a shift in the age distribution of remaining varicella cases toward older ages with higher complication rates.")

Lupus erythematosus disseminatus and vaccination against hepatitis B virus. Mamoux V, et al. Arch Pediatr. 1994 Mar;1(3):307-8. French.

10

Severe acute hepatitis B infection after vaccination. Ballinger AB, et al. Lancet. 1994 Nov 5;344(8932):1292.

Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lilic D, et al. Lancet. 1994 Nov 5;344(8932):1292-3.

Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction. Hughes P, et al. J Pediatr 1994 Jun;124(6):932-5 – (This article reports on the case of a 5-year-old boy in remission from leukemia who experienced approximately 200 vesicular skin lesions 1 month following exposure to live attenuated varicella vaccine. About 2 to 3 weeks later, varicella developed in the boy’s siblings and in three classmates. Swab specimens revealed the presence of vaccine virus in the skin lesions of the boy and his siblings.)

Measles Vaccine Failures: Lack of Sustained Measles Specific Immunoglobulin G Responses in Revaccinated Adolescents and Young Adults. Pediatric Infectious Disease Journal, 13(1), January 1994, p. 34-38.

Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. Stratton KR, et al. JAMA 1994 May 25;271(20):1602-5

Measles Outbreak in 31 Schools: Risk Factors for Vaccine Failure and Evaluation of a Selective Revaccination Strategy. Canadian Medical Association Journal, 150(7), April 1, 1994

Sustained Transmission of Mumps in a Highly Vaccinated Population: Assesment of Primary Vaccine Failure and Waning Vaccine-Induced Immunity," Journal of Infectious Diseases, 169(1), January 1, 1994

Failure to Reach the Goal of Measles Elimination. Apparent Paradox of Measles Infections in Immunized Persons. Archives of Internal Medicine, 154(16), August 22, 1994

Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Strebel PM, et al. Am J Epidemiol 1994 Dec 15;140(12):1111-24

Epidemiology of Guillain-Barre syndrome in children: relationship of oral polio vaccine administration to occurrence. Rantala H, et al. J Pediatr 1994 Feb;124(2):220-3

Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. Briss PA, et al. J Infect Dis 1994 Jan;169(1):77-82

Adverse Reactions Associated with Simultaneous Administration of Multiple Vaccines to Travelers. C. Falvo & H. Horowitz. Journal Gen Intern Medicine, 9(5), May 1994, p. 255-260.

Vaccine-Associated Polio: A Case and Its Lessons. M.V. Mashikian & G.H. Stollerman. Hosp Pract, 29(9), September 15, 1994, p. 69-77.

Disseminated Measles Infection after Vaccination in a Child with a Congenital Immunodeficiency. W.J. Monafo, et al. Journal of Pediatrics, 124(2), February 1994, p. 273-276.

1995

Epiglottitis and Haemophilus influenzae immunization: the Pittsburgh experience--a five-year review. Gonzalez Valdepena H, et al. Pediatrics 1995 Sep;96(3 Pt 1):424-7 – (This study shows that more than 50 percent of cases of epiglottitis induced by Haemophilus influenzae type B were due to vaccine failures. Vaccine failures occurred particularly among recipients of the unconjugated vaccines, but also in people injected with the newer conjugated vaccines.)

Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine. Roberts RJ, et al. BMJ 1995 Jun 24;310(6995):1629-32 . – (This study investigated the reasons for poor uptake of MMR vaccination during a measles outbreak in Wales. Immunization coverage of the campaign was only 43 percent. Fifty-five of 232 parents who reported their reason for vaccination refusal chose "concern about side effects." Symptoms from measles infection were equally common among vaccinated and unvaccinated children, and in fact, fever and rash developed more than twice as often in vaccinated compared to nonvaccinated children. Furthermore, immunized children had a 58-percent increased incidence of joint symptoms compared to those who were not immunized.)

Acute hepatitis B infection after vaccination. Waugh MA. Lancet. 1995 Jan 28;345(8944):262; discussion 262-3.

11

Myelopathy following influenza vaccination. Dutch. Blanco A, et al. Ned Tijdschr Geneeskd. 1995 Oct 21;139(42):2152-4.

Another vaccine, another treadmill? Ferson MJ. J Paediatr Child Health 1995 Feb;31(1):3-5 Nephrotic syndrome after recombinant hepatitis B vaccine. Macario F, et al. Clin Nephrol. 1995

May;43(5):349. Herpes zoster in a normal child after varicella vaccination. Matsubara K, et al. Acta Paediatr Jpn 1995

Oct;37(5):648-50 Acute hepatitis B infection after vaccination. McIntyre PG. Lancet. 1995 Jan 28;345(8944):261. Hearing loss following measles vaccination. Jayarajan V, et al. J Infect. 1995 Mar;30(2):184-5. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination.

Saito H, et al. J Neurol 1995 Feb;242(3):143-6 – (This study shows that 1 out of 6 patients with multiple sclerosis showed worsening of the disease after receiving an influenza vaccination.)

Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Ueda K, et al. Lancet. 1995 Sep 9;346(8976):701-2.

Thrombocytopenia reported in association with hepatitis B and A vaccines. Meyboom RH, et al. Lancet. 1995 Jun 24;345(8965):1638.

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Farrington P, et al. Lancet 1995 Mar 4;345(8949):567-9 – (This study evaluated vaccination records of children hospitalized for convulsions and idiopathic thrombocytopenic purpura (ITP), and found an increased incidence of convulsions after DTP and MMR vaccination. The risk of convulsions attributed to the DTP vaccine was 1 in 12,500 doses and that attributed to the measles component of the MMR vaccine was 1 in 3000 doses. A causal association between MMR vaccination and ITP leading to hospitalization was demonstrated, with an absolute risk of 1 in 24,000 doses. This risk was five times that calculated from cases passively reported by clinicians, thus showing the importance of active rather than passive surveillance of vaccine-related adverse reactions.)

Arthritis after mumps and measles vaccination. Nussinovitch M, et al. Arch Dis Child 1995 Apr;72(4):348-9 Arthritis after hepatitis B vaccination. Report of three cases. Gross K, Combe C, Kruger K, Schattenkirchner

M Scand J Rheumatol 1995;24(1):50-2 Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Sunaga Y, et al. Pediatr Neurol

1995 Nov;13(4):340-2 – (This article reports on the case of a 2-year-old boy who exhibited nausea and vomiting accompanied by staggering gait and dysarthria (difficulty speaking) 10 days after exposure to varicella vaccine. The boy’s condition was subsequently diagnosed as acute cerebellar ataxia.)

Is measles vaccination a risk factor for inflammatory bowel disease? Thompson NP, et al. Lancet 1995 Apr 29;345(8957):1071-4 - (This study evaluated the incidence of Crohn's disease and ulcerative colitis in a cohort of 3545 individuals who received live measles vaccine in 1964 and compared the statistics to the incidence in a control group of approximately 14,000 individuals. Those who received measles vaccination had a 3-fold increased incidence of Crohn's disease and a 2.5-fold increased incidence of ulcerative colitis compared to controls.)

Gait disturbances after measles, mumps, and rubella vaccine. Plesner AM. Lancet. 1995 Feb 4;345(8945):316.

Intrathecal rubella antibodies in an adolescent with Guillain-Barre syndrome after mumps-measles-rubella vaccination. Muhlebach-Sponer M, et al. Eur J Pediatr. 1995 Feb;154(2):166.

Acute Posterior Multifocal Placoid Pigment Epitheliopathy after Hepatitis B Vaccine. A.P. Brezin, et al. Arch Opthalmol, 113(3), March 1995

The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme. Matter L, et al. Eur J Epidemiol 1995 Jun;11(3):305-10

Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents. Clements DA, et al. Pediatr Infect Dis J 1995 Oct;14(10):874-9. – (This study shows that 18.6 percent of children who responded to varicella vaccination (about 5 percent did not respond) developed breakthrough disease after exposure to the infection in the 5-10 years following immunization.)

Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure. Cheek JE, et al. Arch Pediatr Adolesc Med 1995 Jul;149(7):774-8

1996

Childhood Immunization and Diabetes Mellitus, New Zealand Medical Journal May 1996 [1pg] Relapsing acute encephalopathy: a complication of diphtheria-tetanus-poliomyelitis immunization in a young

boy. Mancini J, et al. Eur J Pediatr 1996 Feb;155(2):136-8 - (This article describes the case of a 7-year-old boy who developed demyelinating encephalitis after two diphtheria-tetanus-poliomyelitis vaccinations.)

Type b Haemophilus influenzae meningitis after 2 doses of conjugated vaccine. Moral Gil L, et al.An Esp Pediatr. 1996 Dec;45(6):645-6. Spanish.

12

The diabetes epidemic and the hepatitis B vaccines. Classen JB. N Z Med J 1996 Sep 27;109(1030):366 Systemic lupus erythematosus following hepatitis B vaccine. Guiserix J. Nephron. 1996;74(2):441. Bilateral neuro-papillitis after hepatitis B vaccination. Berkman N, et al. Presse Med. 1996 Sep

28;25(28):1301. French. Multiple evanescent white dot syndrome after hepatitis B vaccine. Baglivo E, et al. Am J Ophthalmol. 1996

Sep;122(3):431-2. Cryoglobulinemia after hepatitis B vaccination. Mathieu E, Fain O, Krivitzky A. N Engl J Med 1996 Aug

1;335(5):355 Occlusion of central retinal vein after hepatitis B vaccination. Devin F, et al. Lancet. 1996 Jun

8;347(9015):1626. Optic neuritis following measles/rubella vaccination in two 13-year-old children. Stevenson VL, et al. Br J

Ophthalmol. 1996 Dec;80(12):1110-1. Haemophilus influenzae type b meningitis in a fully immunized child with a cerebrospinal fluid shunt.

alMohsen I, et al. Pediatr Infect Dis J. 1996 Aug;15(8):706-8. Systemic lupus erythematosus following hepatitis B vaccine. Guiserix J. Nephron. 1996;74(2):441. Leukoencephalitis after recombinant hepatitis B vaccine. Manna R, et al. J Hepatol. 1996 Jun;24(6):764-5. Arthritis, hypercalcemia, and lytic bone lesions after hepatitis B. Cathebras P, et al. J Rheumatol. 1996

Mar;23(3):558-60. Inflammatory Demyelinating Polyradiculoneuropathy. Hughes, RAC, et al. Muscle Nerve 1996; 19: 1230-1. Adverse events associated with MMR vaccines in Japan. Kimura M, et al. Acta Paediatr Jpn, 38(3):205-11

1996 Jun. – (This study evaluated the incidence of aseptic meningitis and convulsions occurring in children receiving the standard MMR vaccine (containing the Urabe strain of mumps virus) or one of three other MMR vaccines produced by different companies. The incidence of serologically confirmed aseptic meningitis per 10,000 vaccinees was 16.6, 11.6, 3.2, and 0 for the standard MMR, Takeda MMR, Kitasato MMR, and Biken MMR vaccines, respectively. The incidence of convulsions was also the highest in recipients of the standard MMR vaccine.)

Clinical trials of varicella vaccine in healthy adolescents and adults. Arbeter AM. Infect Dis Clin North Am 1996 Sep;10(3):609-15 – (This articles admits that adolescents and adults have an increased risk of severe and, rarely, fatal varicella. It also highlights the risk of susceptible parents contracting the disease from their own children.)

Meningeal reaction after vaccination against hepatitis B. Marsaudon E, et al. Presse Med. 1996 Oct 26;25(32):1561-2. French.

Haemophilus influenzae meningitis following vaccination. Consequence or coincidence? Basson E, et al. Arch Pediatr 1996 Apr;3(4):342-4 French. – (This article reports on the case of a 4-month-old who developed--3 hours after vaccination with HiB conjugated vaccine--invasive HiB disease with severe meningitis and blood infection leading to hospitalization. The authors concluded, "Any fever occurring in the immediate post-immunization period must alert [doctors to] the possibility of an HiB infection.")

Acute myelitis after immunization against hepatitis B with recombinant vaccine. Senejoux A, et al. Gastroenterol Clin Biol. 1996;20(4):401-2. French.

Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-merieux serums et vaccins. Jonville-Bera AP, et al. Pediatr Infect Dis J. 1996 Jan;15(1):44-8.

Vaccine-related polio in the US. Modlin JF. Infect Med 13(suppl D):S43-S52, 1996.

Temporal association between the isolation of Sabin-related poliovirus vaccine strains and the Guillain-Barre syndrome. Friedrich F, et al. Rev Inst Med Trop Sao Paulo 1996 Jan-Feb;38(1):55-8

1997

Vaccine Damage, Lancet Jan 1997 [1] Increase in Asthma correlates with Less Childhood Infection, Lancet, Jan 1997 [1pg] Guillain-Barre syndrome after combined tetanus-diphtheria toxoid vaccination. Bakshi R, et al. J Neurol Sci

1997 Apr 15;147(2):201-2 Severe but transient parkinsonism after tetanus vaccination. Reijneveld JC, et al. J Neurol Neurosurg

Psychiatry. 1997 Aug;63(2):258. Acute aseptic meningitis after hepatitis B vaccination. Heinzlef O, et al. Presse Med. 1997 Mar 8;26(7):328.

French. The Risk of Guillain-Barré Syndrome after Tetanus-Toxoid Containing Vaccines in Adults and Children in the

United States. Tuttle J, et al, American Journal of Public Health, December 1997, Vol. 87 (12): 2045-8. Acute pericarditis after vaccination against hepatitis B: a rare effect to be known. Peyriere H, et al. Rev Med

Interne. 1997;18(8):675-6. French. Acute Myelitis after hepatitis B vaccination. Song HK, et al. J Korean Med Sci. 1997 Jun;12(3):249-51.

13

Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? Ranieri VM, et al.Intensive Care Med 1997 Jan;23(1):119-21

Ophthalmic complications of vaccines against hepatitis B virus. Arya SC. Int Ophthalmol. 1997;21(3):177-8. Polyarthritis associated with hepatitis B vaccination. Bracci M, et al Br J Rheumatol. 1997 Feb;36(2):300-1. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after

immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Davis RL, et al. Pediatrics 1997 Nov;100(5):767-71 – (This study shows that children 10 to 12 years old were 50 percent more likely to develop seizures, fever, fatigue, nervous/musculoskeletal symptoms, rash, edema, lymphatic system abnormalities, thrombocytopenia, aseptic meningitis, or joint pain in the 30-day period following MMR vaccination compared to the 30-day period preceding immunization.)

Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases. Granel B, et al. Presse Med. 1997 Feb 1;26(2):62-5. French.

Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. LaRussa P, et al. J Infect Dis 1997 Oct;176(4):1072-5 – (This study reports the case of a woman who developed varicella 12 days after being vaccinated with live attenuated varicella virus. The infection was contagious and spread to her two children. The causative agent was shown to be the vaccine virus.)

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. Black S., et al. Pediatr Infect Dis J, 16(5):500-3 1997 May – (This study found that children receiving the MMR vaccine have a 3.6-fold increased risk of developing aseptic meningitis in the two weeks following vaccination.)

Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. Salzman MB, et al. J Pediatr 1997 Jul;131(1 Pt 1):151-4 – (This article describes the case of a healthy 1-year-old boy who developed varicella 24 days after receiving varicella immunization. Two weeks later, the infection was transmitted to his pregnant mother, who underwent elective abortion. In both cases the causative virus was the vaccine virus.)

Hair loss after routine immunizations. Wise RP, Kiminyo KP, Salive ME JAMA 1997 Oct 8;278(14):1176-8 – (This paper describes 46 cases of alopecia (hair loss) reported to the Vaccine Adverse Effects Reporting System after hepatitis B vaccination.)

Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Tingle AJ, et al. Lancet 1997 May 3;349(9061):1277-81 – (This randomized, double-blind, placebo-controlled trial looked at healthy postpartum women vaccinated with the live attenuated rubella vaccine and followed them up one year after vaccination. At that time, they had a 73-percent increased incidence of acute arthralgia (joint pain) and arthritis, and a 58-percent increased incidence of chronic arthralgia and arthritis, compared to the control-group women, who had received a placebo.)

Mental nerve neuropathy as a result of hepatitis B vaccination. Maillefert JF, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 Jun;83(6):663-4

Measles vaccination and neurological events. Miller D, et al. Lancet. 1997 Mar 8;349(9053):730-1. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event

Reporting System (VAERS), 1991-1994. Braun MM, et al. J Pediatr 1997 Oct;131(4):529-35

Pertussis in the Netherlands: an Outbreak Despite High Levels of Immunization with Whole-Cell Vaccine. De Melker, HE., et al. Emerging Infectious Diseases 3(2):175-178, 1997. Centers for Disease Control.

Apnea after immunization of preterm infants. Sanchez PJ, et al. J Pediatr 1997 May;130(5):746-51

Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994. Braun MM,et al. J Pediatr. 1997 Oct;131(4):529-35

A long-term prospective study of varicella vaccine in healthy children. Johnson CE, et al. Pediatrics 1997 Nov;100(5):761-6 – (This study shows that 20-30 percent of vaccinees developed varicella in the 10 years following immunization.)

High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain). Takayama N, et al. Acta Paediatr Jpn 1997 Dec;39(6):663-8 – (This study shows that 34 percent of individuals vaccinated against chickenpox developed breakthrough disease in the 7-10 years following immunization.)

1998

Hemiparesis following influenza vaccination. Selvaraj N, et al. Postgrad Med J. 1998 Oct;74(876):633-5.

14

Major adverse reactions to yeast-derived hepatitis B vaccines--a review. Grotto I, et al. Vaccine 1998 Feb;16(4):329-34

Exacerbation of chronic juvenile arthritis induced by hepatitis B vaccination. Sebag O, et al.Arch Pediatr. 1998 Sep;5(9):1046. French.

Unilateral total loss of auditory and vestibular function as a complication of mumps vaccination. Kaga K, et al. Int J Pediatr Otorhinolaryngol. 1998 Feb;43(1):73-5.

The development of rheumatoid arthritis after recombinant hepatitis B vaccination. Pope JE, et al. J Rheumatol 1998 Sep;25(9):1687-93

Invasive infection with Haemophilus influenzae type b in spite of complete vaccination. Dutch. Breukels MA, et al. Ned Tijdschr Geneeskd 1998 Mar 14;142(11):586-9

Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Neau D, et al. Scand J Infect Dis. 1998;30(2):115-8. – (This article discusses the cases of seven children (average age--12 years) who developed thrombocytopenia, a bleeding disorder, following vaccination with recombinant hepatitis B vaccine.)

HLA-DR class II associations with rubella vaccine-induced joint manifestations. Mitchell LA, et al. J Infect Dis 1998 Jan;177(1):5-12. – (This study shows that women who received the rubella vaccine postpartum had a 90-percent increased incidence of arthralgia and arthritis compared to those who received a placebo.)

Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Ronchi F, et al. Arch Dis Child. 1998 Mar;78(3):273-4.

Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans. Friedrich F. Acta Virol 1998 Jun;42(3):187-94 – (This article describes some of the neurological complications associated with OPV use, including meningitis, encephalitis, convulsions, transverse myelitis, and Guillain-Barre syndrome. In all cases the causative virus was isolated and identified as the vaccine-type virus.)

Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program. Weibel RE, et al. Pediatrics 1998 Mar;101(3 Pt 1):383-7 – (This study describes 48 children, aged 10 to 49 months, who developed acute encephalopathy within 15 days of receiving measles vaccination. Eight children died, and the remainder had mental regression and retardation, chronic seizures, motor and sensory deficits, and movement disorders. Such reactions occurred with a nonrandom statistically significant distribution on days 8 and 9 from the vaccination, suggesting a causal relationship between measles vaccine and encephalopathy.)

A case of Churg-Strauss vasculitis after hepatitis B vaccination. Vanoli M, et al. Ann Rheum Dis. 1998 Apr;57(4):256-7 – (This article discussess some of the adverse reactions that have been reported following hepatitis B vaccination. These include anaphylaxis (severe allergic response), lupus, and kidney, blood, eye, and nervous system problems.)

Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Wakefield AJ, et al. Lancet, 351(9103):637-41 1998 Feb 28 – (This study examined 12 children who were developmentally normal before vaccination who presented with diarrhea, abdominal pain, and autism (9 children), disintegrative psychosis (1) or possible postviral or vaccinal encephalitis (2). Eight of these children had received MMR vaccination prior to the onset of the symptoms. All 12 children had anatomical and histological alterations of the gut. The authors suggest that a possible increase in intestinal permeability to exogenous molecules may render some individuals more susceptible to the damage caused by environmental triggers.)

Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis. Diamanti E, et al. Vaccine 1998 May-Jun;16(9-10):940-8

1999

Acute disseminated encephalomyelitis associated with tetanus vaccination. Bolukbasi O, et al. Eur Neurol. 1999;41(4):231-2.

Inflammatory bowel disease, autism, and the measles, mumps, and rubella vaccine. Akobeng AK et al. J Pediatr Gastroenterol Nutr, 28(3):351-2 1999 Mar

Uveitis associated with varicella virus vaccine. Esmaeli-Gutstein B, et al. Am J Ophthalmol 1999 Jun;127(6):733-4

Multiple sclerosis and hepatitis B vaccine? Hall A, et al. Vaccine. 1999 Jun 4;17(20-21):2473-5. Vaccination and type 1 diabetes mellitus. Elliman D. BMJ. 1999 May 1;318(7192):1159-60. Cancer risk associated with simian virus 40 contaminated polio vaccine. Fisher SG, et al. Anticancer Res

1999 May-Jun;19(3B):2173-80 Hepatitis B vaccine and central nervous system demyelinating diseases.Viral Hepatitis Prevention Board.

Pediatr Infect Dis J. 1999 Jan;18(1):23-4. Review. Meningoencephalitis: an unusual complication of influenza vaccine. Spanish. Blanco A, et al. Med Clin

(Barc). 1999 May 1;112(15):597.

15

Vaccination against hepatitis B and multiple sclerosis. Diego Nunez MA, et al. An Esp Pediatr. 1999 Jan;50(1):97. Spanish.

Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus. Danish. Christensen CL, et al. Ugeskr Laeger 1999 Feb 8;161(6):794-6 – (This study presents two cases of leukemic children who developed chickenpox 30 days after vaccination. The causative virus was identified as the Oka vaccine strain.)

Increased long term mortality associated with rash after early measles vaccination in rural Senegal. Seng R, et al. Pediatr Infect Dis J 1999 Jan;18(1):48-52

Varicella outbreaks after vaccine licensure: should they make you chicken? Buchholz U, et al. Pediatrics 1999 Sep;104(3 Pt 1):561-3

Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 1999 Jul 22;53(2):396-401.

Association between type 1 diabetes and HiB vaccine. Causal relation is likely. [Letter] Classen JB, et al. BMJ. 1999 Oct 23;319(7217):1133

Cancer risk associated with simian virus 40 contaminated polio vaccine. Fisher SG, et al. Anticancer Res 1999 May-Jun;19(3B):2173-80

Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines. Whittle H, et al. Pediatr Infect Dis J 1999 Jan;18(1):53-7

Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. Galil Ket al. J Infect Dis 1999 Jan;179(1):101-6

Public should be told that vaccines may have long term adverse effects. [Letter] Classen JB, et al. BMJ. 1999 Jan 16;318(7177):193.

2000 (organizing work of list of articles in progress)




Measles Outbreak in a Vaccinated Population in Dhankutta. Jha, N.; Khan, J.; Prasad, R.; George, K.; Shrestha, B. K.; Acharya, B. Nepal Med Coll J; 5 (1): 16-17; June, 2003.




Point: Mandatory Influenza Vaccination for All Heath Care Workers? Seven Reasons to Say "No". Finch, M. Clin Infect Dis; 42 (8): 1141-1143; April 15, 2006.

Blanket Hepatitis B Vaccination Is Questionable in India. Mansfield, P. R.; Phadke, A.; Kale, A. BMJ; 332 (7547): 976; April 22, 2006.

More articles (not in chronological order)

16

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16627533&itool=iconnoabstr&query_hl=30&itool=pubmed_docsum

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16575732&itool=iconnoabstr&query_hl=96&itool=pubmed_docsum

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16583967&itool=iconabstr&query_hl=144&itool=pubmed_docsum

A Persistent Outbreak of Measles Despite Appropriate Prevention And Control Measures (American Journal of Epidemiology Vol 126 No3) [13pgs.]

Seizures Following Childhood Immunizations J of Pediatrics Vol 102 no 1 [7pgs] Severe Acute Hepatitis B Infection After Vaccination Liver Dysfunction and DNA Antibodies After Hepatitis B

Vaccination Thrombocytopenic Purpura After Recombinant Hepatitis B Vaccine, Lancet Vol 344 [2pgs]

1. Anonymous, "License Application for Pertussis Vaccine Withdrawn in Sweden," Lancet, January 14, 1989, p. 114. .

2. P.R. Nader, et al., "Atypical Exanthema Following Exposure to Natural Measles. Eleven Cases of Children Previously Inoculated with Killed Vaccine," Journal of Pediatrics, 72(1), 1968, p. 22-28.

3. G.S. Rachelefsky & K.L. Hermann, "Congenital Rubella Surveillance Following Epidemic Rubella in a Partially Vaccinated Community," Journal of Pediatrics, 84(4), 1974, p. 474-478.

4. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. Poland GA, et al. Arch Intern Med 1994 Aug 22;154(16):1815-20

5. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Miller E, et al. Vaccine 1995 Jun;13(9):799-802

6. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Maldonado YA, et al. Pediatrics 1995 Sep;96(3 Pt 1):447-50

7. Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules. de Francisco A, et al. Vaccine 1998 Apr;16(6):564-8

8. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. Fulginiti VA, et al. JAMA. 1967 Dec 18;202(12):1075-80.

9. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine. Fulginiti VA, et al. JAMA 1980 Aug 22-29;244(8):804-6

10. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Polack FP, et al. Nat Med 1999 Jun;5(6):629-34

11. Mumps epidemiology in Switzerland: results from the Sentinella surveillance system 1986-1993. Sentinella Work Group. German. Zimmermann H, et al. Soz Praventivmed 1995;40(2):80-92

12. Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine. Hillary IB, et al. JAMA 1981 Feb 20;245(7):711-3

13. Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota. Osterholm MT, et al. JAMA 1988 Sep 9;260(10):1423-8

14. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Sood SK, et al. Pediatrics 1990 Apr;85(4 Pt 2):698-704

15. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group. Ward J, et al. N Engl J Med 1990 Nov 15;323(20):1393-401

16. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Booy R, et al. Lancet 1997 Apr 26;349(9060):1197-202

17. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. Urwin G, et al. Clin Infect Dis 1996 Jun;22(6):1069-76

17

18. Outbreak of multiresistant non-encapsulated Haemophilus influenzae infections in a pulmonary rehabilitation centre. Sturm AW, et al. Lancet 1990 Jan 27;335(8683):214-6

19. Association between type 1 diabetes and HiB vaccine. Causal relation is likely. Classen JB, et al. BMJ. 1999 Oct 23;319(7217):1133.

20. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Strebel P, et al. Clin Infect Dis 14:568-579, 1992.

21. Vaccine-related polio in the US. Modlin JF. Infect Med 13(suppl D):S43-S52, 1996.

22. T.M. Pollock, et al., "Symptoms after Primary Immunisation with DPT and with DT Vaccine," Lancet, July 21, 1984, p. 146-149.

23. P.N. Goldwater, et al., "Sudden Infant Death Syndrome: A Possibile Clue to Causation," Medical Journal Aust, 153, 1990, p. 59-60.

24. W.C. Torch, "Diphtheria-pertussis-tetanus (DPT) Immunization: A Potential Cause of the Sudden Infant Death Syndrome (SIDS)," Neurology, 32(4), 1982.

25. L. Bafaff, et al., "Possible Temporal Association Between Diptheria-tetanus Toxoid-pertussis Vaccination in Sudden Infant Death Syndrome," Pediatric Infectious Dis, 2, 1983, p. 7.

26. B.L. Horvath, et al., "Exretion of SV-40 Virus After Oral Administration of Contaminated Polio Vaccine," Acta Microbiology Hungary, 11, p. 271-275.

27. J. Snider, "Near Disaster with Salk Vaccine," Science Digest, 1963.

28. "Division of Biologics Standards: The Boat that Never Rocked Science, March 17, 1972.

29. E.L. Snead, "AIDS - Immunization Related Syndrome," Health Freedom News, July 1987, p. 1.

30. W.C. Douglas, "WHO Murdered Africa," Health Freedom News, September 1987, p. 42.

31. W.S. Kyle, "Simian Retroviruses, Poliovaccine, and Origiin of AIDS," Lancet, March 7, 1992, p. 600-601.

32. C.K.Y. Fong, "Cell Culture Contamination with Adventitious Viral Agents," VA Practitioner, February 1994, p. 60.

33. B.P. McClosky, "The Relation of Prophylactic Inoculation to the Onset of Poliomyelitis," Lancet, April 18, 659-663.

34. T. Francis, et al., "Evaluation of the 1954 Poliomyelitis Vaccine Trials," Poliomyelitis Vaccine Evaluation Center Univeristy of Michigan, Ann Arbor, Michigan, April 12, 1955.

35. "Vaccine Injury Compensation Program Statistics," NVIC News, August 1994, p. 10.

36. S. Holt, et al., "Diffuse Myelitis Associated with Rubella Vaccination," British Medical Journal, 2(6043), October 30, 1976, p. 1037-1038.

37. D.M. Morens, et al., "Reye Syndrome Associated with Vaccination with Live Virus Vaccines. An Exploration of Possible Etiologic Relationships," Clin Pediatr, 18(1), January 1979, p. 42-44.

38. J.M. Lieberman, et al., "Effect of Neonatal Immunization with Diptheria and Tetanus Toxoids on Antibody Responses to Haemophilus Influenzae Type B Conjugate Vaccines," Journal of Pediatrics, 126(2) February 1995, 198-205.

39. J.G. Kelton, "Vaccination-Associated Relapse of Immune Thrombocytopenia," JAMA, 245(4), January 23-30, 1981, p. 369-370.

18

40. K.R. Stratton, et al., "Adverse Events Associated with Childhood Vaccines Other Than Pertussis and Rubella. Summary of a Report from the Institute of Medicine," JAMA, 271(20) May 25, 1994, p. 1602-1606.

41. L. Herroelen, et al., "Central-nervous-system Demyelination after Immunisation with Recombinant Hepatitis B Vaccine," Lancet, 338(8777), November 9, 1991, p. 1174-1175.

42. K.E. Collingham, et al., "Paralytic Poliomyelitis in England and Wales 1976-1977," Lancet, 1(8071), May 6, 1978, p. 976-977.

43. "Measles Pneumonitis Following Measles-mumps-rubella Vaccination of a Patient with HIV Infection, 1993," MMWR, 45(28), July 19, 1996, p. 603-606.

44. P.P. Van Asperen, et al., "Immediate Reactions Following Live Attenuated Measles Vaccine," Medical Journal of Aust, 2(7), October 3, 1981, p. 330-331.

45. L.E. Davis, et al., "Chronic Progressive Poliomyelitis Secondary to Vaccination of an Immunodeficient Child," New England Journal of Medicine, 297(5), August 4, 1977, p. 241-245.

46. P.A. Brunell, et al., "Varicella-like Illness Caused by Live Varicella Vaccine in Children with Acute Lymphocytic Luekemia," Pediatrics, 79(6), June 1987, p. 922-927.

47. F.R. Margolin & T.K. Gandy, "Pneumonia of Atypical Measles," Radiology, 131(3), June 1979, p. 653-655.

48. L.M. Tartaglino, et al., "MR Imaging in a Case of Postvaccination Myelitis," American Journal Neuroradiol, 16(3), March 1995, p. 581-582.

49. M. Kimura, et al., "Adverse Events Associated with MMR Vaccines in Japan," Acta Paediat Jpn, 38(3), June 1996, p. 205-211.

50. K. Matsubara, et al., "Herpes Zoster in a Normal Child after Varicella Vaccination," Acta Paediatr Jpn, 37(5), October 1995, p. 648-650.

51. H. Naruse, et al., "Varicella Infection Complicated with Meningitis after Immunization," Acta Paediatr Jpn, 35(4), August 1993, p. 345-347.

52. , p. 78-80.

53. P. Duclos, et al., "Reporting Vaccine-associated Adverse Events," Canadian Family Physician, 43, September 1997, p. 1551-1560.

54. A. Cosnes, et al., "Inflammatory Nodular Reactions after Hepatitis B Vaccination Due to Aluminum Sensitization," Contact Dermatitis, 23(2), August 1990, p. 65-67.

55. N.H. Cox, et al., "Allergy to Non-toxoid Constituents of Vaccines and Implications for Patch Testing," Contact Dermatitis, 18(3), March 1988, p. 143-146.

56. R.L. Rietschel & R.M. Adams, "Reactions to Thimerosal in Hepatitis B Vaccines," Dermatol Clin, 8(1), January 1990, p. 161-164.

57. M.L. Ciofi degli Atti & P. Olin, "Severe Adverse Events in the Italian and Stockholm I Pertussis Vaccine Clinical Trials," Dev Biol Stand, 89, 1997, p. 77-81.

58. E.J. van de Geijn, et al., "Bilateral Optic Neuritis with Branch Retinal Artery Occlusion Associated with Vaccination," Doc Ophthalmol, 86(4), 1994, p. 403-408.

59. D.J. Pounder, "Sudden, Unexpected Death Following Typhoid-cholera Vaccination," Forensic Sci Int, 24(1), January 1984, p. 95-98.

19

60. C.V. Mohan Rao, et al., "Serological Response to Japanese Encephalitis Vaccine in a Group of School Children in South Arcot District of Tamil Nadu," Indian Journal of Medical Research, 97, March 1993, p. 53-59.

61. L.G. Horowitz, et al., "The Mysterious Origin of HIV: Reviewing the Natural, Iatrogenic, and Genocidal Theories of AIDS," Int Conf AIDS, 11(2), July 7-12, 1996, p. 173.

62. M.J. Ferson, "Another Vaccine, Another Treadmill?" Journal of Paediatr Child Health, 31(1), February 1995, p. 3-5.

63. P. Cathebras, et al., "Arthritis, Hypercalcemia, and Lytic Bone Lesions after Hepatitis B Vaccination," Journal of Rheumatol, 23(3), March 1996, p. 558-560.

64. C. Villanueva, et al., "Vaccination Against the Hepatitis B Virus in Alcoholics," Med Clin, 96(6), February 16, 1991, p. 211-214.

65. R. de Long, "A Possible Cause of Acquired Immune Deficiency Syndrome (AIDS) and Other New Diseases," Medical Hypothesis, 13(4), April 1984, p. 395-397.

66. J.K. Rone & S. Friedstrom, "Severe Systemic Reactions to Typhoid Vaccination: Two Cases and a Review of the Literature," Mil Med, 155(6), June 1990, p. 272-274.

67. R.E. Hoyt & D.S. Herip, "Severe Systemic Reactions Attributed to the Acetone-inactivated Parenteral Typhoid Vaccine," Mil Med, 161(6), June 1996, p. 339-341.

68. J.H. Menkes & M. Kinsbourne, "Workshop on Neurologic Complications of Pertussis and Pertussis Vaccination," Neuropediatrics, 21(4), November 1990, p. 171-176.

69. M. Cizman, et al., "Aseptic Meningitis after Vaccination Against Measles and Mumps," Pediatr Infect Dis Journal, 8(5), May 1989, p. 302-308.

70. E. Ohtaki, et al., "Acute Disseminated Encephalomyelitis after Japanese B Encephalitis Vaccination," Pediatr Neurol, 8(2), March-April 1992, p. 137-139.

71. Y. Sunaga, et al., "Acute Cerebellar Ataxia with Abnormal MRI Lesions after Varicella Vaccination," Pediatr Neurol, 13(4), November 1995, p. 340-342.

72. B. Granel, et al., "Occlusion of the Central Retinal Vein after Vaccination Against Viral Hepatitis B with Recombinant Vaccines. 4 Cases," Presse Med, 26(2), February 1, 1977, p. 62-65.

73. D. Salk, "Eradication of Poliomyelitis in the United States. I. Live Virus Vaccine-associated and Wild Poliovirus Disease," Rev Infec Dis, 2(2), March-April 1980, p. 228-242.

74. E.B. Gurvich, "The Age-dependent Risk of Postvaccination Complications in Vaccines with Smallpox Vaccine," Vaccine, 10(2), 1992, p. 96-97.

75. Z.I. Merekalova, et al., "Possible Connection of the Vaccinia Virus and Carcinogenesis," Vopr Virusol, 32(3), May-June 1987, p. 323-327.

76. J.V. Murphy, et al., "Recurrent Seizures after Diptheria, Tetanus, and Pertussis Vaccine Immunization. Onset Less than 24 Hours after Vaccination," American Journal Disease Children, 138(10), October 1984, p. 908-911.

77. L. Jaber, et al., "Infectious Episodes Following Diptheria-pertussis-tetanus Vaccination. A Preliminary Observation in Infats," Clinical Pediatrics, 27(10), October 1988, p. 491-494.

78. D.G. Hirtz, et al., "Seizures Following Childhood Immunizations," Journal of Pediatrics, 102(1), January 1983, p. 14-18.

20

79. J.W. Gaebler, et al., "Neurologic Complications in Oral Polio Vaccine Recipients," Journal of Pediatrics, 108(6), June 1986, p. 878-881.

80. M.T. Osterholm, et al., "Lack of Efficacy of Haemophilus b Polysaccharide Vaccine in Minnesota," JAMA, 260(10), September 8, 1988, p. 1423-1428.

81. R.W. Sutter, et al., "Outbreak of Paralytic Poliomyelitis in Oman: Evidence for Widespread Transmission Among Fully Vaccinated Children," Lancet, 338(8769), September 21, 1991, p. 715-720.

82. P.M. Strebel, et al., "Intramuscular Injections within 30 Days of Immunization with Oral Poliovirus Vaccine - a Risk Factor for Vaccine-associated Paralytic Poliomyelitis," NEJM, 332(8), February 23, 1995, p. 500-506.

83. C.L. Cody, et al., "Nature and Rates of Adverse Reactions Associated with DTP and DT Immunizations in Infants and Children," Pediatrics, 68(5), November 1981, p. 650-660.

Articles on links between the polio vaccine and AIDSThe Polio Vaccine and AIDS:

Essex, M., et al. “The origin of the AIDS virus.” Scientific American, 1988; 259:64-71. Karpas, A. “Origin and Spread of AIDS.” Nature, 1990; 348:578. Kyle, Walter S. “Simian retroviruses, poliovaccine, and origin of AIDS.” Lancet, 1992; 339:600-601. Elswood, B.F. and Stricker, R.B. “Polio vaccines and the origin of AIDS.” Medical Hypothesis, vol.

42, 1994, pp. 347-354. Myers, G., et al. “The emergence of simian/human immunodeficiency viruses.” AIDS Res Human

Retro 1992: 8:373-86. Workshop on Simian Virus-40 (SV-40): A Possible Human Polyomavirus. (National Vaccine

Information Center, January 27-28, 1997.) www.909shot.com/polio197.htm (Includes a summary of evidence presented at the Eighth Annual Houston Conference on AIDS.)

Martin, Brian. “Polio vaccines and the origin of AIDS: The career of a threatening idea.” Townsend Letter for Doctors (January 1994), pp. 97-100.

Curtis, Tom. “Did a polio vaccine experiment unleash AIDS in Africa?” The Washington Post (April 5, 1992), pp. C3+.

World Health Organization. “T-lymphotropic retroviruses of nonhuman primates.” WHO informal meeting. Weekly Epidemiology Records, 1985; 30:269-70.

Huet, T., et al. “Genetic organization of a chimpanzee lentivirus related to HIV-1.” Nature 1990; 345:356-359.

Desrosiers, R.C. “HIV-1 origins: A finger on the missing link.” Nature 1990; 345:288-89. Sabin, A.B. “Properties and behavior of orally administered attenuated poliovirus vaccine.” Journal

of the American Medical Association 1957; 164: 1216-23. Plotkin, S.A., Koprowski, H., et al. “Clinical trials in infants of orally administered poliomyelitis

viruses.” Pediatrics 1959; 23:1041-62. Barin, F., et al. “Serological evidence for virus related to simian T-lymphotropic retrovirus III in

residents of West Africa.” Lancet 1985; ii:1387-1389. Hirsch, V.M., et al. “Simian immunodeficiency virus infection of macaques: End-stage disease is

characterized by widespread distribution of proviral DNA in tissues.” Journal of Infectious Disease 1991; 163:976-988.

Bohannon, R.C., et al. “Isolation of a Type D retrovirus from B-cell lymphomas of a patient with AIDS.” Journal of Virology 1991; 65(11):5663-72.

Khabbaz, R.F., et al. “Simian immunodeficiency virus needlestick accident in a laboratory worker.” Lancet 1992; 340:271-73.

Gao, F., et al. “Human infection by genetically diverse SIVsm-related HIV-2 in West Africa.” Nature 1992; 358:495-99.

Giunta S., et al. “The primate trade and the origin of AIDS viruses.” Nature 1987; 329:22. Seale, J. “Crossing the species barrier—viruses and the origins of AIDS in perspective.” J R Soc

Med 1989; 82:519-23. Lecatsas G. “Origin of AIDS.” Nature 1991; 351:179.

21

Koprowski, H. “Historical aspects of the development of live virus vaccine in poliomyelitis.” British Medical Journal 1960; ii:85-91.

Lebrun, A., et al. “Vaccination with the CHAT strain of Type 1 attenuated poliomyelitis virus in Leopoldville, Belgian Congo.” Bulletin of the World Health Organization 1960; 22:203-213.

Sabin, A.B. “Present position of immunization against poliomyelitis with live virus vaccines.” British Medical Journal 1959; i:663-680.

Mahmias, A.J., et al. “Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.” Lancet 1986; i:1279-80.

Huminer, D., et al. “AIDS in the pre-AIDS era.” Rev Infect Dis 1987; 9:1102-08. Corbitt, G., et al. “HIV infection in Manchester, 1959.” Lancet 1990; ii:51. Cohen, J. “Debate on AIDS origin: Rolling Stone weighs in — Controversial article angers vaccine

experts by claiming AIDS could have been spread by polio vaccines in Africa.” Science (March 1992), p. 1505. [Article]

Sonnet, J., et al. “Early AIDS cases originating from Zaire and Burtundi (1962-1976).” Scandinavian Journal of Infectious Disease 1987; 19:511-17.

Articles and Congressional Hearings oncorrelations between vaccines and autism

Autism and the MMR (or Measles) Vaccine: Oleske, J. “Elevated rubeola [measles] titers in autistic children.” Abstract presented by D. Zecca

and Dr. Graffino at an NIH meeting (September 23, 1997). As quoted by Richard Gallup in “Autism and autoimmunity.” www.chiroweb.com/archives/18/14/10.html April 15, 2002.

Fudenberg, H.H. “Dialysable lymphocyte extract (DlyE) in infantile onset autism: a pilot study.” Biotherapy 1996; 9:143-147.

Gupta, S. “Immunology and immunologic treatment of autism.” Proceedings of the National Autism Association, Chicago 1996: 455-460.

Wakefield, A.J., et al. “Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.” Lancet 1998; 351:637-641.

Yazbak, F.E. “Autism: Is there a vaccine connection? Part I. Vaccination after delivery.” 1999. http://thinktwice.com/Yazbak1.pdf

Yazbak, F.E. “Autism: Is there a vaccine connection? Part II. Vaccination around pregnancy.” 1999. http://thinktwice.com/Yazbak2.pdf

Yazbak, F.E. “Autism: Is there a vaccine connection? Part III. Vaccination around pregnancy, the sequel.” 2000. http://thinktwice.com/Yazbak3.pdf

“Autism: Present Challenges, Future Needs—Why the Increased Rates?” Government Reform Committee Hearing, Washington, DC. (April 6, 2000.)

Bernard, S., et al. “Autism: a novel form of mercury poisoning,” (July 2000). Submitted to the Government Reform Committee Hearing, Washington, DC. (July 18, 2000.) www.house.gov/reform/healthcare/mercury_paper.htm

“Autism: Why the Increased Rates? A One-Year Update.” Government Reform Committee Hearing, Washington, DC. (April 25-26, 2001.)

“The Autism Epidemic: Is the NIH and CDC Response Adequate?” Government Reform Committee Hearing, Washington, DC. (April 18, 2002.)

“The Status of Research into Vaccine Safety and Autism.” Government Reform Committee Hearing, Washington, DC. (June 19, 2002.)

Kawashima, K., et al. “Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism.” Digestive Diseases and Sciences (April 2000); 45:723-729.

Reuters Medical News. “Measles persistence confirmed in some patients with IBD, autistic enterocolitis.” (June 20, 2000). www.id.medscape.com/reuters/prof/2000/ 06/06.20/20000620scie001.html

Wakefield, A.J. et al. “Enterocolitis in children with developmental disorders.” American Journal of Gastroenterology 2000; 95(9):2154-2156.

Wakefield, A., et al. “Measles, mumps and rubella vaccine: through a glass, darkly.” Adverse Drug Reaction and Toxicologica Reviews 2000; 19(4):265-283.

Kiln MR, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 May 2;351(9112):1358.

22

http://thinktwice.com/Yazbak3.pdf



Selway, "MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance." BMJ 1998 Jun 13;316(7147):1824.

Nicoll A, Elliman D, Ross E, "MMR vaccination and autism 1998," MJ 1998 Mar 7;316(7133):715-716.

Lindley K J, Milla PJ, "Autism, inflammatory bowel disease, and MMR vaccine."Lancet 1998 Mar 21;351(9106):907-908.

Bedford H, et al, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 Mar 21;351(9106):907.

Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108.

Autism and the Smallpox Vaccine:

Eggers, C, "Autistic Syndrome (Kanner) and Vaccinations against Smallpox", Klin Paediatr, Mar 1976, 188(2):172-180.

Articles on links between vaccines and cancer,including leukemia, lymphomas, chromosome changes leading to mutations, and

links between the polio vaccine, a monkey virus (SV-40), and mesotheliomas, brain tumors, bone cancers, and more.

Vaccines, Leukemia and Lymphomas:

Bichel, "Post-vaccinial Lymphadenitis Developing into Hodgkin’s Disease", Acta Med Scand, 1976, Vol 199, p523-525.

Stewart, AM, et al, "Aetiology of Childhood Leukaemia", Lancet, 16 Oct, 1965, 2:789-790. Glathe, H et al, "Evidence of Tumorigenic Activity of Candidate Cell Substrate in Vaccine

Production by the Use of Anti-Lymphocyte Serum", Development Biol Std, 1977, 34:145-148. Bolognesi, DP, "Potential Leukemia Virus Subunit Vaccines: Discussion", Can Research, Feb

1976, 36(2 pt 2):655-656. Colon, VF, et al, "Vaccinia Necrosum as a Clue to Lymphatic Lymphoma", Geriatrics, Dec 1968,

23:81-82. Park-Dincsoy, H et al, "Lymphoid Depletion in a case of Vaccinia Gangrenosa", Laval Med, Jan

1968, 39:24-26. Hugoson, G et al, "The Occurrence of Bovine Leukosis Following the Introduction of Babesiosis

Vaccination", Bibl Haemat, 1968, 30:157-161. Hartstock, , ""Post-vaccinial Lymphadenitis: Hyperplasia of Lymphoid Tissue That Simulates

Malignant Lymphomas", Apr 1968, Cancer, 21(4):632-649. Allerberger, F, "An Outbreak of Suppurative Lymphadenitis Connected with BCG Vaccination in

Austria- 1990/1991," Am Rev Respir Disorder, Aug 1991, 144(2) 469. Omokoku B, Castells S, "Post-DPT inoculation cervical lymphadenitis in children." N Y State J

Med 1981 Oct;81(11):1667-1668.

Vaccines and Chromosome Changes Leading to Mutations:

Knuutila, S et al, "An Increased Frequency of Chromosomal Changes and SCE’s in Cultured Lymphocytes of 12 Subjects Vaccinated Against Smallpox," Hum Genet, 1978 Feb 23; 41(1):89-96.

Cherkeziia, SE, et al, "Disorders in the Murine Chromosome Apparatus Induced By Immunization with a Complex of Anti-viral Vaccines," Vopr Virusol, 1979 Sept Oct, (5):547-550. [SCE means

23

sister chromatid exchange and is an indication that genetic mutations are occurring, which could possibly lead to cancer-causing mutations.]

The Polio Vaccine Has Been Linked to Cancer:

• Shah, K and Nathanson, N. “Human exposure to SV40.” American Journal of Epidemiology, 1976; 103: 1-12.

• Innis, M.D. “Oncogenesis and poliomyelitis vaccine.” Nature, 1968; 219:972-73.

• Soriano, F., et al. “Simian virus 40 in a human cancer.” Nature, 1974; 249:421-24.

• Weiss, A.F., et a;. “Simian virus 40-related antigens in three human meningiomas with defined chromosome loss.” Proceedings of the National Academy of Science 1975; 72(2):609-13. • Scherneck, S., et al. “Isolation of a SV-40-like papovavirus from a human glioblastoma.” International Journal of Cancer 1979; 24:523-31. • Stoian, M., et al. “Possible relation between viruses and oromaxillofacial tumors. II. Research on the presence of SV40 antigen and specific antibodies in patients with oromaxillofacial tumors.” Virologie, 1987; 38:35-40. • Stoian, M., et al. “Possible relation between viruses and oromaxillofacial tumors. II. Detection of SV40 antigen and of anti-SV40 antibodies in patients with parotid gland tumors.” Virologie, 1987; 38:41-46. • Bravo, M.P., et al. “Association between the occurrence of antibodies to simian vacuolating virus 40 and bladder cancer in male smokers.” Neoplasma, 1988; 35:285-88. • O’Connell, K., et al. Endothelial cells transformed by SV40 T-antigen cause Kaposi’s sarcoma-like tumors in nude mice.” American Journal of Pathology, 1991; 139(4):743-49. • Weiner, L.P., et al. “Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy.” New England Journal of Medicine, 1972; 286:385-90. • Tabuchi, K. “Screening of human brain tumors for SV-40-related T-antigen.” International Journal of Cancer 1978; 21:12-17. • Meinke, W., et al. “Simian virus 40-related DNA sequences in a human brain tumor.” Neurology 1979; 29:1590-94. • Krieg, P., et al. “Episomal simian virus 40 genomes in human brain tumors.” Proceedings of the National Academy of Science 1981; 78:6446-50. • Krieg, P., et al. “Episomal Simian Virus 40 Genomes in Human Brain Tumors.” Proceedings of the National Academy of Sciences of the USA, 1981, 78(10):6446-6450. • Krieg, P., et al. “Cloning of SV40 genomes from human brain tumors.” Virology 1984; 138:336-40.

• Geissler, E. “SV40 in human intracranial tumors: passenger virus or oncogenic ‘hit-and-run’ agent?” Z Klin Med, 1986; 41:493-95. • Geissler, E. “SV40 and Human Brain Tumors.” Progress in Medical Virology, 1990; 37:211-222.

• Bergsagel, D.J., et al. “DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood.” New England Journal of Medicine, 1992; 326:988-93. • Martini, M., et al. “Human Brain Tumors and Simian Virus 40.” Journal of the National Cancer Institute, 1995, 87(17):1331. • Lednicky, JA., et al. “Natural Simian Virus 40 Strains are Present in Human Choroid Plexus and Ependymoma Tumors.” Virology, 1995, 212(2):710-17. • Tognon, M., et al. “Large T Antigen Coding Sequence of Two DNA Tumor Viruses, BK and SV-40, and Nonrandom Chromosome Changes in Two Gioblastoma Cell Lines.” Cancer Genetics and Cytogenics, 1996, 90(1): 17-23. • Carbone, M., et al. “SV-40 Like Sequences in Human Bone Tumors.” Oncogene, 1996, 13(3):527-35.

• Pass, HI, Carbone, M., et al. “Evidence For and Implications of SV-40 Like Sequences in Human Mesotheliomas.” Important Advances in Oncology, 1996, pp. 89-108. • Rock, Andrea. “The Lethal Dangers of the Billion Dollar Vaccine Business,” Money, (December 1996), p. 161. [Article] • Carlsen, William. “Rogue virus in the vaccine: Early polio vaccine harbored virus now feared to cause cancer in humans.” San Francisco Chronicle (July 15, 2001), p. 7. [Article: Research by Susan Fisher, epidemiologist, Loyola University Medical Center.] • Bookchin, D. and Schumacher J. “Tainted polio vaccine still carries its threat 40 years later.” The Boston Globe (January 26, 1997). [Article]

24

• Rosa, FW., et al. “Absence of antibody response to simian virus 40 after inoculation with killed-poliovirus vaccine of mothers offspring with neurological tumors.” New England Journal of Medicine, 1988; 318:1469. • Rosa, FW., et al. Response to: “Neurological tumors in offspring after inoculation of mothers with killed poliovirus vaccine.” New England Journal of Medicine, 1988, 319:1226. • Martini, F., et al. “SV-40 Early Region and Large T Antigen in Human Brain Tumors, Peripheral Blood Cells, and Sperm Fluids from Healthy Individuals.” Cancer Research, 1996, 56(20):4820-4825.

Articles on links between vaccines and diabetesVaccines and Diabetes:

Sinaniotis, et al, "Diabetes Mellitus after Mumps Vaccination", Arc Dis Child, 1975, 50:749.66 Polster, H, "Diabetes insipidus after Smallpox vaccination", Z Aerztl Fortbild (Jena), 1 Apr 1966,

60:429-432. Patan, "Postvaccinal Severe Diabetes Mellitus", Ter Arkh, Jul 1968, 40:117-118. Classen, JB, MD, "The Timing of Immunization Affects The Development of Diabetes in Rodents",

Autoimmunity, 1996, 24:137-145. Classen JB, "The diabetes epidemic and the hepatitis B vaccines," N Z Med J, 109(1030):366

1996 Sep 27. [letter] Classen JB, "Childhood immunisation and diabetes mellitus," N Z Med J, 109(1022):195 1996

May 24 [letter] Poutasi K, " Immunisation and diabetes," N Z Med J 1996 Jul 26;109(1026):283. [letter; comment]

Articles Linking Vaccines and Diabetes:

Dokheel, T M, "An Epidemic of Childhood Diabetes in the United States? Evidence from ....", Diabetes Care, 1993, 16:1606-1611.

Parent ME, et al, "Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada," Diabetes Care 1997 May; 20(5):767-772.

House DV, Winter WE, "Autoimmune diabetes. The role of auto-antibody markers in the prediction and prevention of insulin-dependent diabetes mellitus," Clin Lab Med 1997 Sep; 17(3):499-545.

Zeigler, M et al , "[Autoantibodies in type 1 diabetes mellitus]" Z Arztl Fortbild (Jena). 1994 Aug; 88(7-8):561-5

Articles linking vaccines to deafness and blindness Vaccines and Hearing Loss:

Orlando MP, Masieri S, Pascarella MA, Ciofalo A. Filiaci F, et al, “Sudden hearing loss Consequent to Hepatitis B Vaccination: a case report.” Annals of the New York Academy of Sciences. 1997 Dec 29, 830: 319-321

Biacabe B, Erminy M, Bonfils P, et al, “A Case of Fluctuant Sensorineural Hearing Loss consequent to Hepatitis B Vaccination: a case report.” Auris Nasus Larynx. 1997 Oct; 24(4): 357-360.

Watson JG, et al, “A Child of 3 years who developed an Encephalitic Reaction to MMR immunization at age 15 months.” Int J Pediatr Otorhinolaryngol. 1990; 19:189-190.

Mair IW, Elverland HH, et al, “Sudden deafness and vaccination.” J Laryngol Otol. 1977 Apr; 91(4): 323-329.

Stewart, B.J.A., et al. “Reports of sensorineural deafness after measles, mumps, and rubella immunisation.” Archives of Diseases of Childhood 1993; 69:153-54.

Wirth G, et al. “Reversible Kochlearisschadigung nach Tetanol-Injektion? Munch med Wschr. 1965 Aug; 107: 379-381. (Linking Tetanus toxoid in DTaP to hearing loss)

Freed GL, Katz SL, Clark, SJ, et al. “Safety of vaccinations: Miss America, the media, and public health.” JAMA. 1996; 276: 1869-1872.

25

Eavey RD, et al. “Vaccine safety, media reporting, and Miss America.” JAMA. 1997; Jul 23-30; 278(4): 290-291.

Kaga, "Unilateral Total Loss of Auditory and Vestibular Function as a Complication of Mumps Vaccination", Int J Ped Oto, Feb 1998, 43(1):73-73

Nabe-Nielsen, Walter, "Unilateral Total Deafness as a Complication of the Measles- Mumps- Rubella Vaccination", Scan Audio Suppl, 1988, 30:69-70

Hulbert, et al, "Bilateral Hearing Loss after Measles and Rubella Vaccination in an Adult", NEJM, 1991 July, 11;325(2):134

Healy, "Mumps Vaccine and Nerve Deafness", Am J Disorder Child, 1972 Jun; 123(6):612 Jayarajan, Sedler, "Hearing Loss Following Measles Vaccination", J Infect, 1995 Mar; 30(2):184-

185 Pialoux, P et al, "Vaccinations and Deafness", Ann Otolaryng (Paris), Dec 1963, 80:1012-1013. Angerstein, W, et al, "Solitary Hearing and Equilibrium Damage After Vaccinations",

Gesundheitswesen, May 1995, 57(5): 264-268. Brodsky, Stanievich, "Sensorineural Hearing Loss Following Live Measles Virus Vaccination", Int

J Ped Oto, 1985 Nov; 10(2):159-163 Koga, et al, "Bilateral Acute Profound Deafness After MMR Vaccination- Report of a Case",

Nippon Jibiin Gakkai Kai, 1991 Aug;94(8):1142-5 Seiferth, LB, "Deafness after Oral Poliomyelitis Vaccination - a Case Report and Review", HNO,

1977 Aug; 25(8): 297-300 Pantazopoulos, PE, "Perceptive Deafness Following Prophylactic use of Tetanus anittoxin",

Laryngoscope, Dec 1965, 75:1832-1836. Zimmerman, W, "Observation of a case of Acute Bilateral Hearing Impairment Following

Preventive Poliomyelitis Vaccination (type 3)", Arch Ohr Nas Kehlkopfheilk, 1965, 185:723-725.

Vaccines and Vision Loss:

Albitar S, et al. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial Transplant. 1997 Oct;12(10):2169-70.

Achiron LR, et al. Postinfectious hepatitis B optic neuritis. Optom Vis Sci 1994;71:53-6. Arya SC., et al. Ophthalmic complications of vaccines against hepatitis B virus. Int Ophthalmol. 1997;21(3):177-8.

Baglivo E, et al. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol. 1996 Sep;122(3):431-2.

Berkman N, Benzarti T, Dhaoui R, Mouly P., et al. [Bilateral neuro-papillitis after hepatitis B vaccination] Presse Med. 1996 Sep 28;25(28):1301. French.

Berkman N. [A case of segmentary unilateral occlusion of the central retinal vein following hepatitis B vaccination]. Presse Med. 1997 Apr 26;26(14):670. French.

Bienfang DC, et al. Ocular abnormalities after influenza immunization. Arch Ophthalmol. 1977 Sep;95(9):1649.

Bourges JL, Pisella PJ, Laurens C, Limon S. [Multifocal placoid epitheliopathy and anti-hepatitis B vaccination] J Fr Ophtalmol. 1998 Nov;21(9):696-700. French.

Brezin A, et al. Visual loss and eosinophilia after recombinant hepatitis B vaccine. Lancet. 1993 Aug 28;342(8870):563-4.

Brezin AP, Massin-Korobelnik P, Boudin M, Gaudric A, LeHoang P., et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol. 1995 Mar;113(3):297-300.

Fong KS, et al. Multiple evanescent white dot syndrome--an uncommon cause for an enlarged blind spot. Ann Acad Med Singapore. 1996 Nov;25(6):866-8.

Galli M, Morelli R, Casellato A, et al. Retrobulbar optic neuritis in a patient with acute type B hepatitis. Neurol Sci 1986;72:195-200.

Granel B, et al. [Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases]. Presse Med. 1997 Feb 1;26(2):62-5. French.

Hull TP, et al. Optic neuritis after influenza vaccination. Am J Ophthalmol. 1997 Nov;124(5):703-4. Helies P, et al. [Oculo-palpebral complication of vaccination. Review of the literature]. J Fr

Ophtalmol. 1994;17(1):62-6. Review. French. Kazarian EL, et al. Optic neuritis complicating measles, mumps, and rubella vaccination. Am J

Ophthalmol. 1978 Oct;86(4):544-7. Kawasaki A, et al. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J

Neuroophthalmol. 1998 Mar;18(1):56-9. Kline L, Margulies SL, Oh SJ. Optic neuritis and myelitis following rubella vaccination. Arch Neurol

1982;39:443-4.

26

Milkowski S. [Ocular complications following influenza]. Wiad Lek. 1971 Jan 15;24(2):103-8. Polish.

McKibbin M, et al. Bilateral optic neuritis after hepatitis A. J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):508.

Ray CL, et al. Bilateral optic neuropathy associated with influenza vaccination. J Neuroophthalmol. 1996 Sep;16(3):182-4.

Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J. [Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever] Klin Monatsbl Augenheilkd. 2001 Oct;218(10):688-90. German.

Schuil J, van de Putte EM, Zwaan CM, Koole FD, Meire FM. Retinopathy following measles, mumps, and rubella vaccination in an immuno-incompetent girl.Int Ophthalmol. 1998;22(6):345-7.

Solomon A, et al. Bilateral simultaneous corneal graft rejection after influenza vaccination. Am J Ophthalmol. 1996 Jun;121(6):708-9.

Solomon A, et al. Adverse ocular effects following influenza vaccination. Eye. 1999 Jun;13 (Pt 3A):381-2.

Stevenson VL, et al. Optic neuritis following measles/rubella vaccination in two 13-year-old children. Br J Ophthalmol. 1996 Dec;80(12):1110-1.

Kawasaki A, et al. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol. 1998 Mar;18(1):56-9.

Articles on hazards associated with the hepatitis B vaccine

The Hepatitis B Vaccine and Vision Loss: Albitar S, et al. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial

Transplant. 1997 Oct;12(10):2169-70. Achiron LR, et al. Postinfectious hepatitis B optic neuritis. Optom Vis Sci 1994;71:53-6. Arya SC.,

et al. Ophthalmic complications of vaccines against hepatitis B virus. Int Ophthalmol. 1997;21(3):177-8.

Baglivo E, et al. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol. 1996 Sep;122(3):431-2.

Berkman N, Benzarti T, Dhaoui R, Mouly P., et al. [Bilateral neuro-papillitis after hepatitis B vaccination] Presse Med. 1996 Sep 28;25(28):1301. French.

Berkman N. [A case of segmentary unilateral occlusion of the central retinal vein following hepatitis B vaccination]. Presse Med. 1997 Apr 26;26(14):670. French.

Bourges JL, Pisella PJ, Laurens C, Limon S. [Multifocal placoid epitheliopathy and anti-hepatitis B vaccination] J Fr Ophtalmol. 1998 Nov;21(9):696-700. French.

Brezin A, et al. Visual loss and eosinophilia after recombinant hepatitis B vaccine. Lancet. 1993 Aug 28;342(8870):563-4.

Brezin AP, Massin-Korobelnik P, Boudin M, Gaudric A, LeHoang P., et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol. 1995 Mar;113(3):297-300.

Galli M, Morelli R, Casellato A, et al. Retrobulbar optic neuritis in a patient with acute type B hepatitis. Neurol Sci 1986;72:195-200.

Granel B, et al. [Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases]. Presse Med. 1997 Feb 1;26(2):62-5. French.

McKibbin M, et al. Bilateral optic neuritis after hepatitis A. J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):508.

Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J. [Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever] Klin Monatsbl Augenheilkd. 2001 Oct;218(10):688-90. German.

The Hepatitis B Vaccine and Hearing Loss:

Orlando MP, Masieri S, Pascarella MA, Ciofalo A. Filiaci F, et al, “Sudden hearing loss Consequent to Hepatitis B Vaccination: a case report.” Annals of the New York Academy of Sciences. 1997 Dec 29, 830: 319-321

27

Biacabe B, Erminy M, Bonfils P, et al, “A Case of Fluctuant Sensorineural Hearing Loss consequent to Hepatitis B Vaccination: a case report.” Auris Nasus Larynx. 1997 Oct; 24(4): 357-360.

The Hepatitis B Vaccine and Assorted Ailments:

Herroelen L. de Keyser J. Ebinger G. Central nervous system demyelination after immunization with recombinant hepatitis B vaccine. Lancet, 1991 Nov 9; 338 (8776):1174-75.

Ribera ER. Dutka AJ. Polyneuropathy associated with administration of hepatitis B vaccine. N Engl J Med. 1983 Sep 8;309(10):614-5.

Snider GB. Gogate SA. A possible systemic reaction to hepatitis B vaccine. JAMA 1985 Mar 1;253(9):1260-1.

Fried M. Conen D. Conzelmann M. Steinemann E. Uveitis after hepatitis B vaccination. Lancet, 1987 Sep 12;2(8559:631-2.

Shaw FE Jr. Graham DJ. Guess HA, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol 1988 Feb;127(s):337-52.

Biron P. Montpetit P. Infante-Rivard C. Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med. 1988 Dec;148(12):2685.

Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine. N Engl J Med 1989 Oct;321:1198-9.

Anonymous, hepatitis B vaccines: reported reactions. World Health Organization Adverse Drug Reaction Bulletin. August 1990.

Cockwell P. Allen MB. Page R. Vasculitis related to hepatitis B vaccine. BMJ 1990 Dec 1;301(6763):1281.

Tudela P. Marti S. Bonal J. Systemic lupus erthemoatosus and vaccination against hepatitis B. Nephron 1992 62(2):236.

Ganry O. Lerailler F. Vercelleto M. Chiffoleau A. Larouse C. Peripheral facial paralysis following vaccination against hepatitis B. Apropos of a case. Therapie. 1992;47:437-438.

Trevisani F. Gattinara GC. Caraceni P, et al. Transverse myelitis following hepatitis B vaccination. J Hepatol 1993 Sep;19(2):317-8.

Mahassin F. Algayres JP. Valmary J, et al. Acute myelitis after vaccination against hepatitis B. Presse Med 1993 Dec 18;22(40):1997-8.

Nadler JP. Multiple sclerosis and hepatitis B vaccination. Clin Infect Dis 1993 Nov:17(5):928-9. Brezin A. Lautier-Frau M. Hamedani M. Rogeaux O. Hoang PL. Visual loss and eosinophilia after

recombinant hepatitis B vaccine. Lancet 1993 Aug 28;342(8870):563-4. Trevisian G. Stinco G. Lichen rubber planus following HBV vaccination. Acta Dermato-

Venereologica 1993 Feb;73(1):73. Castresana-Isla CJ. Herrera-Martinez G. Vega-Molina J. Erythema nodosum and Takayasu's

arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol 1993 Aug;20(8):1417-8.

Allen MB. Cockwell P. Page RL. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax 1993 May;48(5):580-1.

Deisenhammer F. Pohl P. Bosch S. Schmidauer C. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurol Scand 1994 Jun;89(6):462-3.

Vautier G. Carty JE. Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. Br J Rheumatol 1994 Oct;33(10):991.

Hassan W. Oldham R. Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ 1994 Jul 9;309(6967):94.

Aubin F. Angonin R. Humbert P. Agache P. Lichen planus following hepatitis B vaccination. Archives of Dermatology. 1994 Oct;130(10):1329-30.

Birley HD. Arya OP. Hepatitis B immunisation and reactive arthritis. BMJ 1994 Dec;309(6967):1514.

Poullin P. Gabriel B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet 1994 Nov;344(8932):1293.

Di Lernia V. Lo Scocco G. Bisighini G. Erythema multiforme following hepatitis B vaccine. Ped Derma 1994 Dec;11(4):363-4.

Fraser PA. Wilson JD. Reiter's syndrome attributed to hepatitis B immunisation. BMJ 1994 Dec;309(6967):1513.

Lilic D. Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 1994 Nov;344(8932):1292-3.

Brezin AP. Massin-Korobelnik P. Boudin B., et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthal 1995 Mar;113(3):297-300.

28

Gross K. Combe C. Kruger K. Schattenkkirchner M. Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol. 1995;24(1):50-2.

Kaplanski G. Retornaz F. Durand J. Soubeyrand J. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. J Neurol Neurosurg Psychiatry 1995 Jun;58(6):758-9.

Tartaglino LM. Heiman-Patterson T. Friedman DP. Flanders AE. MR imaging in a case of postvaccination myelitis. AJNR Am J Neuroadiol 1995;16(3):581-2.

Macario F. Freitas L. Correira J., et al. Nephrotic syndrome after recombinant hepatitis B vaccine. Clin Nephrol 1995 May;43(5):349.

Germanaud J. Causse X. Trinh DH., et al. A case of severe cytolysis after hepatitis B vaccination. Amer J Med 1995 Jun;98(6):595-6.

Meyboom RH. Fucik H. Edwards IR. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet 1995 Jun;345(8965):1638.

Aherne P. Collins M. Psoriatic arthropathy. Irish Medical Journal 1995 Mar-Apr;88(2):72. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron 1996;74(2):441. Bonfils P. Biacabe B. Potard G. Aidan D. Fluctuant perception hearing loss after hepatitis B

vaccine. Ann Otolaryngol Chir Cervicofac 1996;113(6):359-61. Baglivo E. Safran AB. Borruat FX. Multiple evanescent white dot syndrome after hepatitis B

vaccine. Am J Ophthalmol 1996 Sep;122(3):431-2. Grezard P. Chefai M. Philipott V. Perrot H. Faisant M. Cutaneous lupus erythematosus and buccal

aphthosis after hepatitis B vaccination in a 6-year old child. Ann Dermatol Venereol. 1996;123(10):657-9.

Classen JB. The diabetes epidemic and the hepatitis B vaccines. New Zealand Med J. 1996 Sep;109(1030):366.

Classen JB. Childhood immunisation and diabetes mellitus. New Zealand Med J 1996 May;109(1022):195.

Manna R. De Santis A. Oliviero A., et al. Leukoencephalitis after recombinant hepatitis B vaccine. J Hepatol. 1996 June;24(6):764-5.

Devin F. Roques G. Disdier P., et al. Occlusion of central retinal vein after hepatitis B vaccination. Lancet 1996 Jun;347(9015):1626.

Cohen AD. Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmunity 1996 Dec;9(6):699-703. Mathieu E. Fain O. Krivitzky A. Cryoglobulinemia after hepatitis B vaccination. New England J Med

1996 Aug;335(5):335. Dauod MS. Dicken CH. Anetoderma after hepatitis B immunization in two siblings. J Amer Acad

Dermo 1997 May;36(5 Pt 1): 779-80. Harrison BJ. Thomson W. Pepper L, et al. Patients who develop inflammatory polyarthritis (IP)

after immunization are clinically indistinguishable from other patients with IP. Br J Rheumatol 1997 Mar;36(3):366-9.

Wise RP. Kiminyo KP. Salive ME. Hair loss after routine immunizations. JAMA 1997 Oct 8;278(14):1176-8.

Song HK. Kim HC. Yun YH. Acute Myelitis after hepatitis B vaccination. J Korean Med Sci 1997 Jun;12(3):249-51.

Granel B. Disdier P. Devin F, et al. Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases. Presse Med 1997 Feb 1;26(2):62-5.

Saywell CA. Wittal RA. Kossard S. Lichenoid reaction to hepatitis B vaccination. Australasian J Derm 1997 Aug;38(3):152-4.

Biacabe B. Erminy M. Bonfils P. A case report of fluctuant sensorineural hearing loss after hepatitis B vaccination. Auris, Nasus, Larynx 1997 Oct;24(4):357-60.

Arya SC. Ophthalmic complications of vaccines against hepatitis B virus. Int Ophth 1997;21(3):177-8.

Bracci M. Zopinni A. Polyarthritis associated with hepatitis B vaccination. British J Rheumatol 1997 Feb;36(2):300-1.

Maillefert JF. Farge P. Gazet-Maillefert MP. Tavernier C. Mental nerve neuropathy as a result of hepatitis B vaccination. Oral Surg Oral Med Orla Path Oral Radio & Endo 1997 Jun;83(6):663-4.

Ranieri VM. Dell'Erba A. Gentile A., et al. Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship?. Intensive Care Medicine 1997 Jan;23(1):119-21.

Kakar A. Sethi PK. Guillain Barre syndrome associated with hepatitis B vaccination. Indian J Ped 1997 Sept-Oct;64(5):710-2.

Orlando MP. Masieri S. Pascarella MA., et al. Sudden hearing loss in childhood consequent to hepatitis B vaccination: a case report. Annals of New York Academy of Sciences 1997 Dec;830:319-21.

Pope JE. Stevens A. Howson W. Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998 Sep;25(9):1687-93.

29

Neau D. Bonnet F. Michaud M, et al. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven case. Scan J. Infect Dis 1998;30(2):115-8.

Ronchi F. Cecchi P. Falcioni F, et al. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Arch Dis Child 1998 Mar;78(3):273-4.

Grasland A. Le Maitre F. Pouchot J, et al. Adult-onset Still's disease after hepatitis A and B vaccination? Rev Med Interne 1998 Feb;19(2):134-6.

Finielz P. Lam-Kam-San LF. Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant 1998;13(9):2420-1.

Le Hello C. Cohen P. Bousser MG. Letellier P. Guillevin L: Suspected hepatitis B vaccination related vasculitis. J Rheumatol, 1999 Jan;26(1):191-4.

Renard JL. Guillamo JS. Ramirez JM, et al. Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti-HBs antibodies. Presse Med 1999 Jul 3-10;28(24):1290-2.

Tourbah A. Gout O. Liblau R. Lyon-Caen O, et al. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 1999 Jul 22;53(2):396-401.

De Keyser F. Naeyaert JM. Hindryckx P, et al. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 2000 Jan-Feb;18(1):81-5.

Konstantinou D. Paschalis C. Maraziotis T, et al. Two episodes of leukoencephalites associated with recombinant hepatitis B vaccination in a single patient. Clin Inf Dis 2001 Nov 15;33:1772-3.

Creange A. Temam G. Lefaucher JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 1999;30:143-6.

Usman A. Kimyai-Asadi A. Stiller MJ. Alam M. Lichenoid eruption following hepatitis B vaccination: first North American case report. Pediatr Dermatol. 2001 Mar-Apr;18(2):123-6.

Conesa V. Nunez MF. Navarro JF. Mompel A. Ruiz J. Gomez A. Thrombocytopenic Purpura after Recombinant Hepatitis B Vaccine. A rare association. Haematologica. 2001 Mar;86(3):E09

Zaas A. Scheel P. Venbrux A. Helmann DB. Large artery vasculitis following recombinant hepatitis B vaccination. 2 cases. J Rheumatol. 2001 May;28(5):1116-20.

Al-Khenaizan S. Lichen planus occurring after hepatitis B vaccination: a new case. J Am Acad Dermatol. 2001 Oct;45(4):614-5.

Barbaud A. Trechot P. Reichert-Penetrat S. Weber M. Schmutz JL. Allergic mechanisms and urticaria/angioedema after hepatitis B immunization. Br J Dermatol. 1998 Nov;139(5):925-6.

Ferrando MF. Doutre MS. Beylot-Barry M. Durand I. Beylot C. Lichen planus following hepatitis B vaccination. Br J Dermatol. 1998 Aug;139(2):350.

Rabaud C. Barbaud A. Trechot P. First case of erythermalgia related to hepatitis B vaccination. Journal of Rheumatol. 26(1):233-4, 1999 Jan.

Schupp P. Vente C. Lichen planus following hepatitis B vaccination. International Journal of Dermatol. 38(10):799-800, 1999 Oct.

Maillefert JF. Sibilia J. Toussirot E., et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatol (Oxford). 1999 Oct;38(10):978-83.

Fledelius HC. Unilateral papilloedema after hepatitis B vaccination in a migraine patient. A case report including forensic aspects. Acta Ophthalmol Scand. 1999 Dec;77(6):722-4.

Muller A. Kertzscher F. Kiefel V. Lenk H. Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-trimoxazole. Eur J Pediatr. 1999 Dec;158 Suppl 3:S209-10.

Stewart O. Chang B. Bradbury J. Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis. Br J Ophthalmol. 1999 Oct;83(10):1200-1.

Islek I. Cengiz K. Cakir M. Kucukoduk S. Nephrotic syndrome following hepatitis B vaccination. Pediatr Nephrol. 2000 Jan;14(1):89-90.

Loche F. Schwarze HP. Thedenat B. Carriere M. Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol. 2000 Mar;25(2):167-8.

Viallard JF. Boiron JM. Parrens M. Moreau JF. Ranchin V. Reiffers J. Leng B. Pellegrin JL. Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol. 2000 Jul;110(1):230-3.

Toussirot E. Lohse A. Wendling D. Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheumatol. 2000 Sep;43(9):2139-40.

Sinsawaiwong S. Thampanitchawong P. Guillain-Barre syndrome following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai. 2000 Sep;83(9):1124-6.

Agrawal S. Garg VK. Joshi A. Agarwalla A. Sah SP. Lichen planus after HBV vaccination in a child: a case report from Nepal. J Dermatol. 2000 Sep;27(9):618-20.

Flemmer M. Oldfield EC 3rd. The bald truth. Am J Gastroenterol. 1999 Apr;94(4):1104. Gran B. Bielekova B. McFarland HF. Martin R. Development of Multiple Sclerosis after hepatitis B

vaccination. Neurol 2000;54(suppl 3):A164.

30

Biasi D. Carletto A. Caramaschi P. Frigo A. Pacor M. Bezzi D., et al. Rheumatological manisfestations following hepatitis B vaccination. Report of three cases. Scand J Rheumatol. 1995;24:50-52.

Rogerston SJ. Nye FJ. Hepatitis B vaccine associated with erythema nodosum and poly arthritis. BMJ. 1990;301:345.

Wieland KK. Cohen MR. Hepatitis B vaccine: Recombivax reaction. Nursing. 88;18:87. Mamoux V. Dumont C. Lupus erthymatosus disseminatus and vaccination against hepatitis B

virus. Arch Pediatr. 1994;1:307-309. Martinez E. Domingo P. Evan's syndrome triggered by recombinant hepatitis B vaccine. Clin Infect

Dis. 1992;15:1051. AADRAC. Australian Adverse Drug Reactions Advisory Committee: Reactions to hepatitis B

vaccines. Austr Adv Drug React Bull;1990. Nagafuchi S. Tokiyam K. Kashiwagi S. Yayashi S. Imayama S. Niho Y. Eosinophillia after

intradermal hepatitis B vaccination. Lancet. 1993;342:998.

Articles about links between vaccines and immune system damage, including autoimmunity and autism

Vaccines and Autoimmunity:

Romanov, V A, et al, "Role of Auto-immune Processes in the Pathogenesis of Post-Vaccinal Lesions of the Nervous System", Oct 1977, Zh Mikrobiol Epidemiol Immunobiol, 10:80-83.

Grachev, V P, et al, "Formation of Auto-antibodies in Laboratory Animals After Inoculation of Viruses With Different Virulence. I. Results of Studies ..., July 1973, Acta Virol (Praha), 17:319-326.

Movsesiants, AA, et al, "Experimental Study of the Ability of Different Strains of Vaccinia Virus to Induce Auto-Antibody Formation", Vopr Virusol, May-Jun 1975; (3):297-302.

Negina, IuP, "Comparative Study of Auto-antibody Formation Following Immunization With Different Types of Typhoid Vaccines", Zh Mikrobiol Epidemiol Immunobiol, May 1980; (5):69-72.

Vaccines and Autism:

Eggers, C, "Autistic Syndrome (Kanner) And Vaccinations against Smallpox", Klin Paediatr, Mar 1976, 188(2):172-180.






Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108. ["None of the autistic children in the study had measles in the past, but all had the MMR" stated David Whalgren.

Articles on hazards associated with the MMR (Measles, Mumps and Rubella) and measles

vaccines

31

The MMR Vaccine: Albonico, H., Klein, P., et al. “The immunization campaign against measles, mumps and rubella—

coercion leading to a realm of uncertainty: medical objections to a continued MMR immunization campaign in Switzerland.” JAM 1992; 9(1). [180 European medical doctors oppose the use of MMR.]


Templeton, S. “MMR vaccine should not have been licensed.” Sunday Herald (London: December 10, 2000). [Article]

Petrovic, M., et al. “Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.” British Medical Journal 2001; 322:82-85. [Doctors and nurses do not recommend it.]

BBC News. “Why Japan stopped using MMR,” (February 8, 2002). www.news.bbc.co.uk/hi/english/world/asia-pacific/newsid_1808000/1808316.stm

The MMR (or Measles) Vaccine and Autism:

Oleske, J. “Elevated rubeola [measles] titers in autistic children.” Abstract presented by D. Zecca and Dr. Graffino at an NIH meeting (September 23, 1997). As quoted by Richard Gallup in “Autism and autoimmunity.” www.chiroweb.com/archives/18/14/10.html (April 15, 2002.)

Fudenberg, H.H. “Dialysable lymphocyte extract (DlyE) in infantile onset autism: a pilot study.” Biotherapy 1996; 9:143-147.

Gupta, S. “Immunology and immunologic treatment of autism.” Proceedings of the National Autism Association, Chicago 1996: 455-460.

Wakefield, A.J., et al. “Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.” Lancet 1998; 351:637-641.

Yazbak, F.E. “Autism: Is there a vaccine connection? Part I. Vaccination after delivery.” 1999. www.garynull.com/documents/autism99b.htm

Yazbak, F.E. “Autism: Is there a vaccine connection? Part II. Vaccination around pregnancy.” 1999. www.garynull.com/documents/autism99b2.htm

Yazbak, F.E. “Autism: Is there a vaccine connection? Part III. Vaccination around pregnancy, the sequel.” 2000. www.garynull.com/documents/autism99b3.htm

“Autism: Present Challenges, Future Needs—Why the Increased Rates?” Government Reform Committee Hearing, Washington, DC. (April 6, 2000.)

“Autism: Why the Increased Rates? A One-Year Update.” Government Reform Committee Hearing, Washington, DC. (April 25-26, 2001.)

“The Autism Epidemic: Is the NIH and CDC Response Adequate?” Government Reform Committee Hearing, Washington, DC. (April 18, 2002.)

“The Status of Research into Vaccine Safety and Autism.” Government Reform Committee Hearing, Washington, DC. (June 19, 2002.)

Kawashima, K., et al. “Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism.” Digestive Diseases and Sciences (April 2000); 45:723-729.

Reuters Medical News. “Measles persistence confirmed in some patients with IBD, autistic enterocolitis.” (June 20, 2000). www.id.medscape.com/reuters/prof/2000/06/06.20/20000620scie001.html

Wakefield, A.J. et al. “Enterocolitis in children with developmental disorders.” American Journal of Gastroenterology 2000; 95(9):2154-2156.







32

Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108.

The Measles (and MMR) Vaccine and Neurological Disorders(Including Central Nervous System Damage, subacute sclerosing panencephalitis [brain disease], and Guillain-Barre' syndrome [paralysis]):

Schneck, S.A. “Vaccination with measles and central nervous system disease.” Neurology 1968; 18 (Part 2):79-82.

Jabbour, J.T., et al. “Epidemiology of subacute sclerosing panencephalitis (SSPE).” Journal of the American Medical Association 1972; 220:959-62.

Belgamwar, R.B., et al. “Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis.” Journal of the Indian Medical Association 1997; 95(11):594.

Landrigan, P.J., et al. “Neurological disorders following live measles-virus vaccination.” Journal of the American Medical Association 1973; 223 (13):1459-62.

Miller, C.L. Lancet (September 17, 1983). Beale, A.J. “Measles vaccines.” Proceedings of the Royal Society of Medicine 1974; 67:1116-

1119. Roden, A.T. “Fits following immunization.” Proceedings of the Royal Society of Medicine 1974;

67:24. Jagdis, F., et al. “Encephalitis after administration of live measles vaccine.” Journal of the

Canadian Medical Association (April 19, 1975); 112(8):972-75. Hirayama, M. “Measles vaccines used in Japan.” Reviews of Infectious Diseases 1983; 5:495-503. Pollock, T.M., et al. “A 7-year survey of disorders attributed to vaccination in Northwest Thames

Region.” Lancet 1983; 1:753-57. Jorch, G. et al. “Coincidence of virus encephalitis and measles-mumps vaccination.” Monatsschr

Kinderheilkd 1984; 132(5):299-300. Martinon-Torres, F., et al. “Self-limited acute encephalopathy related to measles component of viral

triple vaccine.” Rev Neurol (May 1-15, 1999); 28(9):881-82. Grose, C., et al. “Guillain-Barré syndrome following administration of live measles vaccine.”

American Journal of Medicine 1976; 60:441-43. Norrby, R. “Polyradiculitis in connection with vaccination against morbilli, parotitis and rubella.”

Lakartidningen 1984; 81:1636-37. Morris, K., et al. “Guillain-Barré syndrome after measles, mumps, and rubella vaccine.” Lancet

1994; 343:60.

The Measles (and MMR) Vaccine and Serious Blood Disorders:

Oski, F.A. and Naiman, J.L. “Effect of live measles vaccine on the platelet count.” New England Journal of Medicine 1966; 265:352-56.

Bottiger, M., et al. “Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.” British Medical Journal 1987; 295:1264-67.

Koch, J. et al. “Adverse events temporally associated with immunizing agents—1987 report.” Canada Diseases Weekly Report 1989; 15:151-58.

Fescharek, R., et al. “Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects.” Vaccine 1990; 8:446-56.

Nieminen, U., et al. “Acute thrombocytopenic purpura following measles, mumps and rubella vaccination: A report on 23 patients.” Acta Paediatrica 1993; 82:267-70.

146. Farrington, P., et al. “A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.” Lancet 1995; 345: 567-69.

Jonville-Bera, A.P., et al. “Thrombocytopenic purpura after measles, mumps, and rubella vaccination: a retrospective survey by the French Regional Pharmacovigilance Centres and Pasteur-Merieux Serums et Vaccins.” Pediatr Infect Dis J 1996; 15:44-48.

Beeler, J. et al. “Thrombocytopenia after immunization with measles vaccines: review of the Vaccine Adverse Events Reporting Systerm (1990-1994).” Pediatr Infect Dis J 1996; 15:88-90.

The Measles (and MMR) Vaccine and Sensory Impairments(Including Eye Disorders and Hearing Loss):

33

Kazarian, E.L., et al. “Optic neuritis complicating measles, mumps, and rubella vaccination.” American Journal of Ophthalmology 1978; 86:544-47.

Marshall, G.S., et al. “Diffuse retinopathy following measles, mumps, and rubella vaccination.” Pediatrics 1985; 76:989-991.

Brodsky, L., et al. “Sensorineural hearing loss following live measles virus vaccination.” International Journal of Pediatric Otorhinolaryngology 1985; 10:159-63.

Nabe-Nielsen, J., et al. “Unilateral deafness as a complication of the mumps, measles, and rubella vaccination.” British Medical Journal 1988; 297:489.

Hulbert, T.V., et al. “Bilateral hearing loss after measles and rubella vaccination in an adult.” New England Journal of Medicine 1991; 325:134.

Stewart, B.J.A., et al. “Reports of sensorineural deafness after measles, mumps, and rubella immunisation.” Archives of Diseases of Childhood 1993; 69:153-54.

The Measles (and MMR) Vaccine and Immune System Damage(Other Than Autism):

Hirsch, R.L., et al. “Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production.” Clinical Immunology and Immunopathology 1981; 21:341-50.

Nicholson, J.K.A., et al. “The effect of measles-rubella vaccination on lymphocyte populations and subpopulations in HIV-infected and healthy individuals.” Journal of Acquired Immune Deficiency Syndromes 1992; 5:528-537.

The Measles (and MMR) Vaccine and Bowel Disease:

Thompson, N.P., Wakefield, A.J, et al. “Is measles vaccination a risk factor for inflammatory bowel disease?” Lancet 1995; 345:1071-1074.

Barton, J.R., et al. “Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983: marginal fall in ulcerative colitis; three-fold rise in Crohn’s disease.” Gut 1989; 30:618-622.

Whelan, G. “Epidemiology of inflammatory bowel disease.” Med Clin N Am 1990; 74:1-12. Ekbom, A., et al. “The role of perinatal measles infection in the aetiology of Crohn’s disease: a

population-based epidemiological study.” Lancet 1994; 334:508-510. Miyamoto, H., et al. “Detection of immunoreactive antigen with monoclonal antibody to measles

virus in tissue from patients with Crohn’s disease.” Journal of Gastroenterology 1995; 30:28-33. Wakefield, A.J., et al. “Evidence of persistent measles virus infection in Crohn’s disease.” Journal

of Medical Virology 1993; 39:345-53. Wakefield, A.J., et al. “Crohn’s disease: pathogenesis and persistent measles virus infection.”

Gastroenterology 1995; 108:911-916. Lewin, J., et al. “Confirmation of persistent measles virus infection of intestinal tissue by

immunogold electron microscopy.” Gut 1995; 36:564-69.

The Measles (and MMR) Vaccine and Severe Allergic Reactions:

Aukrust, L., et al. “Severe hypersensitivity or intolerance reactions to measles vaccine in six children: clinical and immunological studies.” Allergy 1980; 35(7):581-87.

McEwen, J. “Early-onset reaction after measles vaccination: further Australian reports.” Medical Journal of Australia 1983; 2:503-505.

Koch, J., et al. “Adverse events temporally associated with immunizing agents—1987 report.” Canada Diseases Weekly Report 1989; 15:151-58.

Kelso, J.M., et al. “Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin.” J Allergy Clin Immunol 1993; 91:867-72.

Sakaguchi, M., et al. “IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines.” J Allergy Clin Immunol 1995; 96:563-65.

The Measles Vaccine and "Atypical" Measles:

Cherry, J.D. “The ‘new’ epidemiology of measles and rubella.” Hospital Practice (July 1980), pp. 53-54.

Fulginiti, V.A., et al. “Altered reactivity to measles virus; atypical measles in children previously immunized with inactivated measles virus vaccines.” Journal of the American Medical Association 1967; 202:1075.

34

Martin, D.B., et al. “Atypical measles in adolescents and young adults.” Annals of Internal Medicine 1979; 90:877.

Gold, E. “Current progress in measles eradication in the United States.” Infect Med 1997; 14(4):297-300, 310.

Nichols, E.M. “Atypical measles: a continuing problem.” American Journal of Public Health 1979; 69(2):160-62.

Scott, T.F., et al. “Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine.” New England Journal of Medicine 1967; 277(5):248-251.

Cherry, J.D., et al. “Atypical measles in children previously immunized with attenuated measles virus vaccines.” Pediatrics 1972; 50(5).

St. Geme, J.W., et al. “Exaggerated natural measles following attenuated virus immunization.” Pediatrics 1976; 57:148-150.

“Atypical measles syndrome.” Lancet 1979, pp. 962-963.

The Measles Death Rate Tumbled Prior to the Measles Vaccine:

Alderson, Michael. International Mortality Statistics (Washington, DC: Facts on File, 1981), pp. 182-183.

The Measles Vaccine is Ineffective(Outbreaks Often Occur Among Highly, or Fully, Vaccinated Populations):

FDA. “FDA workshop to review warnings, use instructions, and precautionary information [on vaccines].” (Rockland, Maryland: FDA, September 18, 1992), p. 27.

Faich, G.A., et al. “Measles outbreak in Rhode Island.” Public Health Report 1981 May-June; 96(3):264-266.

CDC. MMWR (February 1, 1985). CDC. MMWR (June 1984). CDC. MMWR (June 6, 1987). Gustafson, T. “Measles outbreak in a fully immunized secondary school population.” New England

Journal of Medicine 1987; 316:771-74. Markowitz, L.E., et al. “Patterns of transmission in measles outbreaks in the United States, 1985-

1986.” New England Journal of Medicine 1989; 320:75-81. Robertson, S.E., et al. “A million dollar measles outbreak: epidemiology, risk factors, and a

selective revaccination strategy.” Public Health Reports (January-February 1992), p. 24. Edmonson, M.B., et al. “Mild measles and secondary vaccine failure during a sustained outbreak in

a highly vaccinated population.” Journal of the American Medical Association 1990; 263:2467-71. Minnesota Department of Health. “Measles summary, 1987.” CDC. “Measles.” MMWR 1989; 38:329-330. CDC. “Measles—Quebec.” MMWR 1989; 38:329-30. CDC. “Measles—United States, 1990. MMWR 1991; 40(2):369. CDC. “U.S. Childhood Immunization Update: Measles.” (March 1997). CDC. “Measles—United States, 1999.” MMWR 2000; 49(25): 557-560.

Natural Immunity is Superior:

CDC. “Babies of vaccinated moms more susceptible to measles.” Pediatrics (November 1999). “Natural immunity to measles yields greater neutralizing capacity than vaccination.” Journal of

Medical Virology 2000; 62:91-98.

The Measles Vaccine Alters the Epidemiology of the Disease (It Causes Higher Rates of Measles in High-Risk Groups):

Cherry, J.D. “The ‘new’ epidemiology of measles and rubella.” Hospital Practice (July 1980), p. 51. Macgregor, J.D., et al. “Epidemic measles in Shetland during 1977 and 1978.” British Medical

Journal 1981; 282(6262):434-436. Gold, E. “Current progress in measles eradication in the United States.” Infect Med 1997;

14(4):297-300, 310. CDC. “Measles—United States, 1999.” MMWR 2000; 49(25): 557-560.

Authorities Experimented on Children with a Proven Deadly Measles Vaccine:

35

Sabin, A.B., et al. “Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.” JAMA 1983; 249:2651-62.

Sabin, A.B., et al. “Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. JAMA 1984; 251:2363-71.

Whittle, H.C., et al. “Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.” Lancet 1984; ii:834-37.

Whittle, H., et al. “Trial of high-dose Edmonston-Zagreb measles vaccine in The Gambia: antibody response and side-effects.” Lancet 1988; ii:811-814.

Aaby, P., et al. “Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.” Lancet 1988; i:809-811.

Garenne, M., et al. “Child mortality after high-titre measles vaccines: prospective study in Senegal.” Lancet 1991; 338:903-907.

Whittle, H.C. “Effect of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months.” Lancet 1988; i:963-66.

Khanum, S., et al. “Comparison of Edmonston-Zagreb and Schwartz strains of measles vaccine given by aerosol or subcutaneous injection.” Lancet 1987; i:150-53.

Tidjani, O., et al. “Serological effects of Edmonston-Zagreb, Schwartz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.” Lancet 1989; ii:1357-60.

Markowitz, L.E., et al. “Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwartz measles vaccines.” New England Journal of Medicine 1990; 332:580-87.

Awadu, K.O. Outrage! How Babies Were Used as Guinea Pigs in an L.A. County Vaccine Experiment. (Long Beach, CA: Conscious Rastra Press, 1996).

Articles on hazards associated with the mumps vaccineThe Mumps Vaccine and Neurological Disorders:

Bottiger, M., et al. “Swedish experience og two dose vaccination programme aiming at eliminating measles, mumps and rubella.” British Medical Journal 1987; 295:264-67.

Thomas, E. “A case of mumps meningitis: A complication of vaccination?” Journal of the Canadian Medical Association 1988; 138:135.

Champagne, S., et al. “A case of mumps meningitis: a post-immunization complication?” Canadian Disease Weekly Report 1988; 13-35:155-156.

Ehrengut, W. “Mumps vaccine and meningitis.” Lancet 1989; 2:751. Von Muhlendahl, K.E. “Mumps meningitis following measles, mumps and rubella immunisations.”

Lancet (August 12, 1989), p. 394. Cizman, M., et al. “Aseptic meningitis after vaccination against measles and mumps.” Pediatric

Infectious Disease Journal 1989; 8:302-308. McDonald, J., et al. “Clinical and epidemiological features of mumps meningo-encephalitis and

possible vaccine-related disease.” Pediatric Infectious Disease Journal (November 1989), pp. 751-754.

Gray, J.A., et al. “Mumps meningitis following measles, mumps, and rubella immunisation.” Lancet 1989; i:98.

Gray, J.A., et al. “Mumps vaccine meningitis.” Lancet 1989; i:927. Murray, M.W., et al. “Mumps meningitis after measles, mumps, and rubella immunisation.” Lancet

1989; ii:877.\ “Mumps meningitis and MMR vaccination.” [Editorial] Lancet 1989; ii:1015-1016. Forsey, T., et al. “Mumps viruses and mumps, measles, and rubella vaccine.” British Medical

Journal 1989; 299:1340. Forsey, T., et al. “Mumps vaccines and meningitis.” Lancet 1992; 340:980. Miller, E., et al. “Risk of aseptic meningitis after measles, mumps, and rubella vaccine in U.K.

children.” Lancet 1993; 341:979. Sawada, et al. Lancet 1993; 342:371.

36

The Mumps Vaccine and Meningitis Attack Rates:

Sugiura, A., et al. “Aseptic meningitis as a complication of mumps vaccination.” Journal of Pediatric Infectious Diseases 1991; 10:209-213. [1 case of meningitis per 2000 doses of mumps vaccine.]

Fujinaga, T., et al. “A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine.” Journal of Pediatric Infectious Diseases 1991; 10:204-209. [6 cases of meningitis per 2000 doses of mumps vaccine.]

Colville, A., et al. “Mumps meningitis and measles, mumps, and rubella vaccine.” Lancet 1992; 340:786. [1 case of meningitis per 3800 doses of mumps vaccine.]

The Mumps Vaccine and Diabetes:

Sultz, H.A., et al. “Is mumps virus an etiologic factor in juvenile diabetes mellitus?” Journal of Pediatrics 1975; 86:654-656.

Sinaniotis, C.A., et al. “Diabetes mellitus after mumps vaccination (letter).” Archives of Disease in Childhood 1975; 50:749-750.

Quast, U., et al. “Vaccine-induced mumps-like diseases.” Developments in Biological Standardization 1979; 43:269-272.

Otten, A., et al. “Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I.” Behring Institute Mitteilungen 1984; 75:83-88.

Helmke, K., et al. “Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination.” Diabetologia 1986; 29:30-33.

Fescharek, R., et al. “Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects.” Vaccine 1990; 8:446-456.

Pawlowski, B., et al. “Mumps vaccination and type-1 diabetes.” Deutsche Medizinische Wochenschrift 1991; 116:635.

Adler, J.B., et al. “Pancreatitis caused by measles, mumps, and rubella vaccine.” Pancreas 1991; 6:489-490.

Albonico, H., Klein, P., et al. “The immunization campaign against measles, mumps and rubella—coercion leading to a realm of uncertainty: medical objections to a continued MMR immunization campaign in Switzerland.” JAM 1992; 9(1). [180 European medical doctors jointly noted that the mumps vaccine "can trigger diabetes, which only becomes apparent months after vaccination."]

Atypical Mumps:

Gunby, P. “‘Atypical’ mumps may occur after immunization.” Journal of the American Medical Association 1980; 243(23): 2374-75.

Family Practice News (July 15, 1980), p. 1.

The Mumps Vaccine is Often Ineffective and Alters the Epidemiology of the Disease (It Causes Higher Rates of Mumps in High-Risk Groups):

Fiumara, N.J., et al. “Mumps outbreak in Westwood, Massachusetts—1981.” MMWR 1982; 33(29):421-430.

Kaplan, K.M., et al. “Further evidence of the changing epidemiology of a childhood vaccine-preventable disease.” Journal of the American Medical Association 1988; 260(10):1434-1438.

Briss, P. A., et al. “Sustained transmission of mumps in a highly vaccinated population: assessment of vaccine failure and waning vaccine-induced immunity.” Journal of Infectious Diseases 1994; 169:77-82.

Sawada, et al. Lancet 1993; 342:371. CDC. “Mumps—United States, 1985-1988.” MMWR 1989; 38:101-05.

Girls who contract mumps naturally during childhood are less likely to develop ovarian cancer in later life :

West, R. “Epidemiologic study of malignancies of the ovaries.” Cancer 1966; 19:1001-1007. Wynder, E., et al. “Epidemiology of cancer of the ovary.” Cancer 1969; 23:352. Newhouse, M., et al. “A case control study of carcinoma of the ovary.” Brit J Prev Soc Med 1977;

31:148-53.

37

McGowan, L., et al. “The woman at risk from developing ovarian cancer.” Gynecol Oncol 1979; 7:325-344.

Articles on links between vaccines and neurological disorders,

including: alterations to the nervous system, autism, demyelination, seizures, convulsions, epilepsy, brain swelling, and other neurological complications.

Vaccines and Nervous System Changes:

Bondarev, VN et al, "The Changes of the Nervous System in Children After Vaccination", Pediatria, Jun 1969; 48:20-24.

Ehrengut W, "Central nervous sequelae of vaccinations," Lancet 1986 May 31;1(8492):1275-1276.

Provvidenza, G et al, [On a Case of Benign Acute Cerebellar Ataxia in Childhood], Arch Ital Sci Med Trop, 43:189-194, Apr 1962.

Katsilambros, L, "[The Phenomenom of Apathy in Man and Animals After the Injection of Viruses in Very High Doses. Clinical Data]", Rev Med Moyen Orient, 20:539-546, Nov - Dec 1963.

Vaccines and Autism:

Eggers, C, "Autistic Syndrome (Kanner) And Vaccinations against Smallpox", Klin Paediatr, Mar 1976, 188(2):172-180.






Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108. ["None of the autistic children in the study had measles in the past, but all had the MMR" stated David Whalgren.

Vaccines and Demyelination:

Herroelen, L et al, "Central-Nervous-System Demyelination After Immunization with Recombinant Hepatitis B Vaccine", Lancet, Nov 9, 1991, 338(8776):1174-1175.

Kaplanski G, Retornaz F, Durand J, Soubeyrand J, "Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype." J Neurol Neurosurg Psychiatry 1995 Jun; 58(6):758-759.

Matyszak MK, Perry VH, "Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guerin." Neuroscience 1995 Feb;64(4):967-977.

Tornatore CS, Richert JR, "CNS demyelination associated with diploid cell rabies vaccine." Lancet 1990 Jun 2;335(8701):1346-1347.

Adams, JM et al, "Neuromyelitis Optica: Severe Demyelination Occurring Years After Primary Smallpox Vaccinations", Rev Roum Neurol, 1973, 10:227-231.

In 1988, Dietrich used MRI to show that developmentally delayed children had alterations in their myelin. Coulter described that central nervous system damage can be exhibited as abnormal behavior of the child. In 1935, Thomas Rivers, experimental allergic encephalitis (EAE) can be the result of a viral or bacterial infection of the nervous system. "The fact of the matter is that it is a matter of record that it was known that vaccination produced encephalitis since 1926." The authors stated, "In regions in which there is no organized vaccination of the population, general paralysis is

38

rare. ... It is impossible to deny a connection between vaccinations and the encephalitis (brain damage) which follows it." Vaccines have been linked to seizures, convulsions and epilepsy.

Vaccines and Seizures:

Hirtz DG, Nelson KB, Ellenberg J H, "Seizures following childhood immunizations", Pediatr 1983 Jan; 102(1):14-18.

Cherry JD, Holtzman AE, Shields WD, Buch D, Nielsen, "Pertussis immunization and characteristics related to first seizures in infants and children,"J Pediatr 1993 Jun;122(6):900-903.

Coplan J, "Seizures following immunizations," J Pediatr 1983 Sep;103(3):496. Barkin RM, Jabhour JT, Samuelson J S, "Immunizations, seizures, and subsequent evaluation,"

JAMA 1987 Jul 10;258(2):201. Griffin MR, et al, "Risk of seizures after measles-mumps-rubella immunization," Pediatrics 1991

Nov;88(5):881-885. Griffin MR, et al, "Risk of seizures and encephalopathy after immunization with the diphtheria-

tetanus-pertussis vaccine," JAMA 1990 Mar 23-30;263(12):1641-1645. Cizewska S, Huber Z, Sluzewski W, "[Prophylactic inoculations and seizure activity in the EEG],"

Neurol Neurochir Pol 1981 Sep-Dec;15(5-6):553-557. [Article in Polish] Huttenlocher PR, Hapke RJ, "A follow-up study of intractable seizures in childhood." Ann Neurol

1990 Nov; 28(5):699-705. Blumberg DA, "Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed

study of children with seizures, hypotonic-hypo-responsive episodes, high fevers, and persistent crying."Pediatrics 1993 Jun; 91(6):1158-1165.

Vaccines and Convulsions:

Prensky AL, et al, "History of convulsions and use of pertussis vaccine," J Pediatr 1985 Aug; 107(2):244-255.

Baraff LJ, "Infants and children with convulsions and hypotonic-hypo-responsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation," Pediatrics 1988 Jun; 81(6):789-794.

Jacobson V, "Relationship of pertussis immunization to the onset of epilepsy, febrile convulsions and central nervous system infections: a retrospective epidemiologic study," Tokai J Exp Clin Med 1988;13 Suppl: 137-142.

Cupic V,et al, "[Role of DTP vaccine in the convulsive syndromes in children]," Lijec Vjesn 1978 Jun; 100(6):345-348. [Article in Serbo-Croatian (Roman)]

Pokrovskaia NIa, "[Convulsive syndrome in DPT vaccination (a clinico-experimental study)]," Pediatriia 1983 May;(5):37-39. [Article in Russian]

Vaccines and Epilepsy:

Ballerini, Ricci, B, et al, "On Neurological Complications of Vaccination, With Special Reference to Epileptic Syndromes," Riv Neurol, Jul-Aug 1973, 43:254-258.

Wolf SM, Forsythe A, "Epilepsy and mental retardation following febrile seizures in childhood," Acta Paediatr Scand 1989 Mar;78(2):291-295.

Vaccines and Brain Swelling:

Iwasa, S et al, "Swelling of the Brain in Mice Caused by Pertussis ... Quantitative Determination and the Responsibility of the Vaccine", Jpn J Med Sci Biol, 1985 , 38(2):53-65.

Mathur R, Kumari S, "Bulging fontanel following triple vaccine." Indian Pediatr 1981 Jun;18(6):417-418.

Barry W, Lenney W, Hatcher G, "Bulging fontanelles in infants without meningitis." Arch Dis Child 1989 Apr;64(4):635-636.

Shendurnikar N, "Bulging fontanel following DPT" Indian Pediatr 1986 Nov;23(11):960. Gross TP, Milstien JB, Kuritsky JN, "Bulging fontanelle after immunization with diphtheria-

tetanus-pertussis vaccine and diphtheria-tetanus vaccine." J Pediatr 1989 Mar;114(3):423-425.

39

Jacob J, Mannino F, "Increased intracranial pressure after diphtheria, tetanus, and pertussis immunization." Am J Dis Child 1979 Feb;133(2):217-218.

Dugmore, WN, "Bilateral Oedema at the Posterior Pole. Hypersensitivity Reaction to Alavac P injection." Br J Ophthalmol, Dec 1972, 55:848-849.

Vaccines and Neurological Damage:

Nedar P R, and Warren, R J, "Reported Neurological Disorders Following Live Measles Vaccine", 1968, Ped, 41:997-1001.

Paradiso, G et al, "Multifocal Demyelinating Neuropathy after Tetanus Vaccine", Medicina (B Aires), 1990, 50(1):52-54.

Landrigan, PJ, Whitte, J, "Neurologic Disorders Following Live Measles-virus Vaccination", JAMA, Mar 26, 1973, v223(13):1459-1462.

Turnbull, H M, "Encephalomyelitis Following Vaccination", Brit Jour Exper Path, 7:181, 1926. Kulenkampff, M et al, "Neurological Complications of Pertussis Inoculation", Arch Dis Child,

1974, 49:46. Strom, J, "Further Experience of Reactions, Especially of a Cerebral Nature in Conjunction with

Triple Vaccination", Brit Med Jour, 1967, 4:320-323. Berg, J M, "Neurological Complications of Pertussis Immunization," Brit Med Jour, July 5,1958; p

24. Bondarev, VN et al, "The Changes of the Nervous System in Children After Vaccination",

Pediatria, Jun 1969; 48:20-24. Badalian, LO, "Vaccinal Lesions of the Nervous System in Children," Vop Okhr Materin Dets,

Dec 1959, 13:54-59 Lorentz, IT, et al, "Post-Vaccinal Sensory Polyneuropathy with Myoclonus", Proc Aust Ass

Neurol, 1969, 6:81-86. Trump, R C, White, T R, "Cerebellar Ataxia Presumed Due To Live Attenuated Measles Virus

Vaccine," JAMA, 1967, 199:165-166. Allerdist, H, "Neurological Complications Following Measles Vaccination", Inter Symp, Brussels,

1978, Development Biol Std, Vol 43, 259-264. Finley, K H, "Pathogenesis of Encephalitis Occurring With Vaccination, Variola and Measles, Arch

Neur and Psychologist, 1938; 39:1047-1054. Froissart, M et al, "Acute Meningoencephalitis Immediately after an Influenza Vaccination", Lille

Med, Oct 1978, 23(8):548-551. Pokrovskaia, Nia, et al, "Neurological Complications in Children From Smallpox Vaccination",

Pediatriia, Dec 1978, (12):45-49. Allerdist, H, "Neurological Complications Following Measles Virus Vaccination. Evaluation of the

Cases seen Between 1971-1977", Monatsschr Kinderheilkd, Jan 1979, 127(1): 23-28. Ehrengut, W et al, "On Convulsive Reactions Following Oral vaccination Against Polio", Klin

Paediatr, May 1979, 191(3):261-270. Naumova, R P, et al, "Encephalitis Developing After Vaccination without a Local Skin Reaction",

Vrach Delo, Jul 1979, (7):114-115. Goswamy, BM, "Neurological Complications After Smallpox Vaccination", J Ass Phys India, Jan

1969, 17:41-43. Schchelkunov, SN et al, "The Role of Viruses in the Induction of Allergic Encephalomyelitis,"

Dokl Akad Nauk SSSR, 1990,315(1):252-255. [Vaccines contain viruses, too] Walker AM, "Neurologic events following diphtheria-tetanus-pertussis immunization," Pediatrics

1988 Mar;81(3):345-349. Shields WD, et al, "Relationship of pertussis immunization to the onset of neurologic disorders: a

retrospective epidemiologic study," J Pediatr 1988 Nov; 113(5):801-805. Wilson J, "Proceedings: Neurological complications of DPT inoculation in infancy," Arch Dis

Child 1973 Oct; 48(10):829-830. Iakunin IuA, "[Nervous system complications in children after preventive vaccinations],"

Pediatriia 1968 Nov; 47(11):19-26. [Article in Russian] Greco D, et al, "Case-control study on encephalopathy associated with diphtheria-tetanus

immunization in Campania, Italy," Bull World Health Organ 1985;63(5):919-925. Ehrengut W at Institute of Vaccinology and Virology, Hamburg, Germany states, "Bias in the

evaluation of CNS complications following pertussis immunization are the following: 1) Notifications of post-immunization adverse events, 2) Publications by vaccine producers on the frequency of adverse reactions, 3) Comparison of permanent brain damage after DPT and DT immunization, 4) Pro-immunization, 5) Immunization associated viral encephalitis, 6) Accuracy of statistics, 7) Personal. A review of these points indicates an underestimation of CNS complications after pertussis immunization."

40

Reference: Ehrengut W, "Bias in evaluating CNS complications following pertussis immunization." Acta Paediatr Jpn, 1991 Aug; 33(4):421-427.

Articles on hazards associated with the polio vaccine Numerous Studies Show That Vaccine Injections Cause Paralytic Polio:

Houchaus. “Ueber Poliomyelitis acuta.” Munch Med Wochenschr 1909; 56:2353-55. Lambert, S.M. “A yaws campaign and an epidemic of poliomyelitis in Western Samoa.” J Trop Med

Hyg 1936; 39:41-46. McCloskey, B.P. “The relation of prophylactic inoculations to the onset of poliomyletis.” Lancet

(April 18, 1950), pp. 659-63. Geffen, D.H. “The incidence of paralysis occurring in London children within four weeks after

immunization.” Med Officer 1950; 83:137-40. Martin, J.K. “Local paralysis in children after injections.” Arch Dis Child 1950; 25:1-14. Hill, A.B., et al. “Inoculation and poliomyelitis. A statistical investigation in England and Wales in

1949.” British Medical Journal 1950; ii:1-6. Medical Research Council Committee on Inoculation Procedures and Neurological Lesions.

“Poliomyelitis and prophylactic inoculation.” Lancet 1956; ii:1223-31. Sutter, Roland W., et al. “Attributable risk of DTP (Diphtheria and Tetanus Toxoids and Pertussis

Vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman.” Journal of Infectious Diseases 1992; 165:444-9.

Strebel, Peter M., et al. “Intramuscular injections within 30 days of immunization with oral poliovirus vaccine—a risk factor for vaccine-associated paralytic poliomyelitis.” New England J of Med (February 23, 1995), pp. 500+.

Editorial. “Provocation paralysis.” Lancet 1992; 340:1005. Wyatt, H.V. “Provocation poliomyelitis: neglected clinical observations from 1914-1950.” Bulletin of

Historical Medicine 1981; 55:543-57. Townsend-Coles, W.F and Findlay, G.M. “Poliomyelitis in relation to intramuscular injections of

quinine and other drugs.” Trans R Soc Trop Med Hyg 1953; 47:77-81. Guyer, B., et al. “Injections and paralytic poliomyelitis in tropical Africa.” Bull WHO 1980; 58:285-

91. Bodian, D. “Viremia in experimental poliomyelitis. II. Viremia and the mechanism of the 'provoking'

effect of injections of trauma.” Amer J Hyg 1954; 60:358-70. Wyatt, H.V. “Incubation of poliomyelitis as calculated from time of entry into the central nervous

system via the peripheral nerve pathways.” Rev Infect Dis 1990; 12:547-56. Wyatt H.V., et al. “Unnecessary injections and paralytic poliomyelitis in India.” Trans R Soc Trop

Med Hyg 1992; 86:546-49.

The Oral Polio Vaccine Is a Major Cause of Polio:

Strebel, Peter M., et al. “Epidemiology of poliomyletis in U.S. one decade after the last reported case of indigenous wild virus associated disease,” Clinical Infectious Diseases (CDC, February 1992), pp. 568-79.

Gorman, Christine. “When the vaccine causes the polio.” Time (October 30, 1995), p. 83. [Article] Shaw, Donna. “Unintended casualties in war on polio.” Philadelphia Inquirer (June 6, 1993), p. A1.

[Article]

The Polio Death Rate Was Declining Before the Vaccine Was Introduced:

Alderson, Michael. International Mortality Statistics (Washington, DC: Facts on File, 1981), pp. 177-78.

The Standards for Defining Polio Were Altered When the Polio Vaccine Was Introduced. (By making simple changes to the diagnostic criteria, the number of Polio cases was predetermined to decrease.)

41

Hearings Before the Committee on Interstate and Foreign Commerce, House of Representatives, 87th Congress, 2nd Session on HR 10541. May 1962, pp. 94-112.

The Polio Vaccine Has Been Linked to Cancer:

Shah, K and Nathanson, N. “Human exposure to SV40.” American Journal of Epidemiology, 1976; 103: 1-12.

Innis, M.D. “Oncogenesis and poliomyelitis vaccine.” Nature, 1968; 219:972-73. Soriano, F., et al. “Simian virus 40 in a human cancer.” Nature, 1974; 249:421-24. Weiss, A.F., et a;. “Simian virus 40-related antigens in three human meningiomas with defined

chromosome loss.” Proceedings of the National Academy of Science 1975; 72(2):609-13. Scherneck, S., et al. “Isolation of a SV-40-like papovavirus from a human glioblastoma.”

International Journal of Cancer 1979; 24:523-31. Stoian, M., et al. “Possible relation between viruses and oromaxillofacial tumors. II. Research on

the presence of SV40 antigen and specific antibodies in patients with oromaxillofacial tumors.” Virologie, 1987; 38:35-40.

Stoian, M., et al. “Possible relation between viruses and oromaxillofacial tumors. II. Detection of SV40 antigen and of anti-SV40 antibodies in patients with parotid gland tumors.” Virologie, 1987; 38:41-46.

Bravo, M.P., et al. “Association between the occurrence of antibodies to simian vacuolating virus 40 and bladder cancer in male smokers.” Neoplasma, 1988; 35:285-88.

O’Connell, K., et al. Endothelial cells transformed by SV40 T-antigen cause Kaposi’s sarcoma-like tumors in nude mice.” American Journal of Pathology, 1991; 139(4):743-49.

Weiner, L.P., et al. “Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy.” New England Journal of Medicine, 1972; 286:385-90.

Tabuchi, K. “Screening of human brain tumors for SV-40-related T-antigen.” International Journal of Cancer 1978; 21:12-17.

Meinke, W., et al. “Simian virus 40-related DNA sequences in a human brain tumor.” Neurology 1979; 29:1590-94.

Krieg, P., et al. “Episomal Simian Virus 40 Genomes in Human Brain Tumors.” Proceedings of the National Academy of Sciences of the USA, 1981, 78(10):6446-6450.

Krieg, P., et al. “Cloning of SV40 genomes from human brain tumors.” Virology 1984; 138:336-40. Geissler, E. “SV40 in human intracranial tumors: passenger virus or oncogenic ‘hit-and-run’

agent?” Z Klin Med, 1986; 41:493-95. Geissler, E. “SV40 and Human Brain Tumors.” Progress in Medical Virology, 1990; 37:211-222. Bergsagel, D.J., et al. “DNA sequences similar to those of simian virus 40 in ependymomas and

choroid plexus tumors of childhood.” New England Journal of Medicine, 1992; 326:988-93. Martini, M., et al. “Human Brain Tumors and Simian Virus 40.” Journal of the National Cancer

Institute, 1995, 87(17):1331. Lednicky, JA., et al. “Natural Simian Virus 40 Strains are Present in Human Choroid Plexus and

Ependymoma Tumors.” Virology, 1995, 212(2):710-17. Tognon, M., et al. “Large T Antigen Coding Sequence of Two DNA Tumor Viruses, BK and SV-40,

and Nonrandom Chromosome Changes in Two Gioblastoma Cell Lines.” Cancer Genetics and Cytogenics, 1996, 90(1): 17-23.

Carbone, M., et al. “SV-40 Like Sequences in Human Bone Tumors.” Oncogene, 1996, 13(3):527-35.

Pass, HI, Carbone, M., et al. “Evidence For and Implications of SV-40 Like Sequences in Human Mesotheliomas.” Important Advances in Oncology, 1996, pp. 89-108.

Rock, Andrea. “The Lethal Dangers of the Billion Dollar Vaccine Business,” Money, (December 1996), p. 161. [Article]

Carlsen, William. “Rogue virus in the vaccine: Early polio vaccine harbored virus now feared to cause cancer in humans.” San Francisco Chronicle (July 15, 2001), p. 7. [Article: Research by Susan Fisher, epidemiologist, Loyola University Medical Center.]

Bookchin, D. and Schumacher J. “Tainted polio vaccine still carries its threat 40 years later.” The Boston Globe (January 26, 1997). [Article]

Rosa, FW., et al. “Absence of antibody response to simian virus 40 after inoculation with killed-poliovirus vaccine of mothers offspring with neurological tumors.” New England Journal of Medicine, 1988; 318:1469.

Rosa, FW., et al. Response to: “Neurological tumors in offspring after inoculation of mothers with killed poliovirus vaccine.” New England Journal of Medicine, 1988, 319:1226.

Martini, F., et al. “SV-40 Early Region and Large T Antigen in Human Brain Tumors, Peripheral Blood Cells, and Sperm Fluids from Healthy Individuals.” Cancer Research, 1996, 56(20):4820-4825.

42

The Polio Vaccine and AIDS:

Essex, M., et al. “The origin of the AIDS virus.” Scientific American, 1988; 259:64-71. Karpas, A. “Origin and Spread of AIDS.” Nature, 1990; 348:578. Kyle, Walter S. “Simian retroviruses, poliovaccine, and origin of AIDS.” Lancet, 1992; 339:600-601. Elswood, B.F. and Stricker, R.B. “Polio vaccines and the origin of AIDS.” Medical Hypothesis, vol.

42, 1994, pp. 347-354. Myers, G., et al. “The emergence of simian/human immunodeficiency viruses.” AIDS Res Human

Retro 1992: 8:373-86. Workshop on Simian Virus-40 (SV-40): A Possible Human Polyomavirus. (National Vaccine

Information Center, January 27-28, 1997.) www.909shot.com/polio197.htm (Includes a summary of evidence presented at the Eighth Annual Houston Conference on AIDS.)

Martin, Brian. “Polio vaccines and the origin of AIDS: The career of a threatening idea.” Townsend Letter for Doctors (January 1994), pp. 97-100.

Curtis, Tom. “Did a polio vaccine experiment unleash AIDS in Africa?” The Washington Post (April 5, 1992), pp. C3+.

World Health Organization. “T-lymphotropic retroviruses of nonhuman primates.” WHO informal meeting. Weekly Epidemiology Records, 1985; 30:269-70.

Huet, T., et al. “Genetic organization of a chimpanzee lentivirus related to HIV-1.” Nature 1990; 345:356-359.

Desrosiers, R.C. “HIV-1 origins: A finger on the missing link.” Nature 1990; 345:288-89. Sabin, A.B. “Properties and behavior of orally administered attenuated poliovirus vaccine.” Journal

of the American Medical Association 1957; 164: 1216-23. Plotkin, S.A., Koprowski, H., et al. “Clinical trials in infants of orally administered poliomyelitis

viruses.” Pediatrics 1959; 23:1041-62. Barin, F., et al. “Serological evidence for virus related to simian T-lymphotropic retrovirus III in

residents of West Africa.” Lancet 1985; ii:1387-1389. Hirsch, V.M., et al. “Simian immunodeficiency virus infection of macaques: End-stage disease is

characterized by widespread distribution of proviral DNA in tissues.” Journal of Infectious Disease 1991; 163:976-988.

Bohannon, R.C., et al. “Isolation of a Type D retrovirus from B-cell lymphomas of a patient with AIDS.” Journal of Virology 1991; 65(11):5663-72.

Khabbaz, R.F., et al. “Simian immunodeficiency virus needlestick accident in a laboratory worker.” Lancet 1992; 340:271-73.

Gao, F., et al. “Human infection by genetically diverse SIVsm-related HIV-2 in West Africa.” Nature 1992; 358:495-99.

Giunta S., et al. “The primate trade and the origin of AIDS viruses.” Nature 1987; 329:22. Seale, J. “Crossing the species barrier—viruses and the origins of AIDS in perspective.” J R Soc

Med 1989; 82:519-23. Lecatsas G. “Origin of AIDS.” Nature 1991; 351:179. Koprowski, H. “Historical aspects of the development of live virus vaccine in poliomyelitis.” British

Medical Journal 1960; ii:85-91. Lebrun, A., et al. “Vaccination with the CHAT strain of Type 1 attenuated poliomyelitis virus in

Leopoldville, Belgian Congo.” Bulletin of the World Health Organization 1960; 22:203-213. Sabin, A.B. “Present position of immunization against poliomyelitis with live virus vaccines.” British

Medical Journal 1959; i:663-680. Mahmias, A.J., et al. “Evidence for human infection with an HTLV III/LAV-like virus in Central

Africa, 1959.” Lancet 1986; i:1279-80. Huminer, D., et al. “AIDS in the pre-AIDS era.” Rev Infect Dis 1987; 9:1102-08. Corbitt, G., et al. “HIV infection in Manchester, 1959.” Lancet 1990; ii:51. Cohen, J. “Debate on AIDS origin: Rolling Stone weighs in — Controversial article angers vaccine

experts by claiming AIDS could have been spread by polio vaccines in Africa.” Science (March 1992), p. 1505. [Article]

Sonnet, J., et al. “Early AIDS cases originating from Zaire and Burtundi (1962-1976).” Scandinavian Journal of Infectious Disease 1987; 19:511-17.

The Polio Vaccine is Mutating, Causing Virulent Strains

Crainic, R., et al. “Polio virus with natural recombinant genomes isolated from vaccine associated paralytic poliomyelitis.” Virology 1993; 196:199-208.

Yoshida, H., et al. Lancet (October 28, 2000).

43

Reuters Health. “Polio outbreak in Dominican Republic and Haiti Caused by vaccine-derived virus.” Reuters Medical News (December 4, 2000). www.id.medscape.com/reuters/prof/2000/12/12.05/20001204epid001.html

Articles on hazards associated with therubella vaccine

Rubella Vaccines Produced in Dog Kidneys and Duck Embryos: Spruance, S.L., et al. “Recurrent joint symptoms in children vaccinated with HPV-77DK12 rubella

vaccine.” Journal of Pediatrics 1972;80(3):413-17. Hilleman, M.R., et al. “Live attenuated rubella virus vaccines: experiences with duck embryo cell

preparations.” American Journal of Diseases of Children 1969; 118:166-171. Cherry, J.D. “The ‘new’ epidemiology of measles and rubella.” Hospital Practice (July 1980), pp.

53-54.

Rubella Vaccines Produced in Lung Tissues of Dissected Human Fetuses:

Plotkin, S.A. “Development of RA 27/3 attenuated rubella virus grown in WI-38 cells.” Wistar Institute of Anatomy and Biology. Cited in International Symposium on Rubella Vaccines, London 1968; Symposium Series on Immunobiol. Standards (Karger, Basel/New York, 1969); 11:249-260.

Hayflick, L., et al. “The serial cultivation of human diploid cell strains.” Exp. Cell Res. 1961; 25:585-621.

Plotkin, S.A., et al. “Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted foetus.” Amer. J. Dis. Child. 1965; 110:381-389.

Hoskins, J.M., et al. “Behaviour of rubella virus in human diploid cell strains. I. Growth of virus. II. Studies of infected cells.” Arch. ges. Virusforsch 1967; 21:283-296.

Hayflick, L. “The limited in vitro lifetime of human diploid cell strains.” Exp. Cell Res. 1965; 37:614-636.

Physician’s Desk Reference (PDR); 55th edition. (Montvale, NJ: Medical Economics, 2001), p. 1966.

The Rubella Vaccine and Arthritis:

Cooper, L.Z., et al. “Transient arthritis after rubella vaccination.” Am J Dis Child 1969; 118:218-225.

Spruance, S.L., et al. “Joint complications associated with derivatives of HPV-77 rubella virus vaccine.” American Journal of Diseases in Children 1971; 122:105-111.

Swartz, T.A., et al. “Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.” American Journal of Epidemiology 1971; 94:246-51.

Weibel, R.E., et al. “Influence of age on clinical response to HPV-77 duck rubella vaccine.” J. of American Medical Association 1972; 222:805-807.

Thompson, G.R., et al. “Intermittent arthritis following rubella vaccination: a three year follow-up.” American Journal of Diseases of Children 1973; 125:526-530.

Chantler, J.K., et al. “Persistent rubella infection and rubella-associated arthritis.” Lancet (June 12, 1982):1323-1325.

Tingle, A.J., et al. “Prolonged arthritis, viraemia, hypogamma-globulinaemia, and failed seroconversion following rubella immunisation.” Lancet 1984; 1:1475-1476.

Tingle, A.J., et al. “Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.” Journal of Infectious Diseases 1985; 152:606-612.

Tingle, A.J., et al. “Rubella-associated arthritis. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation.” Annals of the Rheumatic Diseases 1986; 45:110-114.

Institute of Medicine. Adverse Effects of Pertussis and Rubella Vaccines. (Washington, DC: National Academy Press, 1991).

44

Benjamin, C.M., et al. “Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine.” British Medical Journal 1992; 304:1075-78.

The Rubella Vaccine and Neurological Disorders:

Kilroy, A.W., et al. “Two syndromes following rubella immunization.” Journal of the American Medical Association 1970; 214:2287-2292.

Gilmarten, R.C., et al. “Rubella vaccine myeloradiculoneuritis.” Journal of Pediatrics 1972; 80:406-412.

Schaffner, W., et al. “Polyneuropathy following rubella immunization: a follow-up study and review of the problem.” American Journal of Diseases of Children 1974; 127:684-688.

Institute of Medicine. Adverse Effects of Pertussis and Rubella Vaccines. (Washington, DC: National Academy Press, 1991).

Mühlebach-Sponer, M., et al. “Intrathecal rubella antibodies in an adolescent with Guillain-Barré syndrome after mumps-measles-rubella vaccination.” European Journal of Pediatrics 1994; 154:166.

The Rubella Vaccine and Diabetes:

Menser, M., et al. “Rubella infection and diabetes mellitus.” Lancet (January 14, 1978), pp. 57-60. Rayfield, E.J., et al. “Rubella virus-induced diabetes in the hamster.” Diabetes (December 1986);

35:1278-1281. Ehrengut, W. “Central nervous system sequelae of immunization against measles, mumps, rubella

and poliomyelitis.” Acta Paediatrica Japonica 1990; 32:8-11. Aubrey, J., et al. “Postpartum rubella immunization: association with development of prolonged

arthritis, neurological sequelae, and chronic rubella viremia.” Journal of Infectious Diseases (September 1985); 152(3):606-612.

Coulter, Harris. “Childhood vaccinations and Juvenile-Onset (Type-1) diabetes.” Congressional Testimony. Committee on Appropriations, subcommittee on Labor, Health and Human Services, Education, and Related Agencies. (April 16, 1997).

Coyle, P.K., et al. “Rubella-specific immune complexes after congenital infection and vaccination.” Infection and Immunity (May 1982); 36(2):498-503.

Numazaki, K., et al. “Infection of cultured human fetal pancreatic islet cells by rubella virus.” American Journal of Clinical Pathology 1989; 91:446-451.

The Rubella Vaccine and Chronic Fatigue Syndrome:

Tobi, M., et al. “Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection.” Lancet 1982; 1:61-64.

Bicker, U. “Some new aspects of autoimmunity.” Journal of Immuno-pharmacology 1986; 8:543-559.

Allen, A.D. “Is RA27/3 rubella immunization a cause of Chronic Fatigue?” Medical Hypotheses 1988; 27:217-220.

Lieberman, A.D. “The role of the rubella virus in the chronic fatigue syndrome.” Clinical Ecology 1991; 7(3):51-54.

The Rubella Vaccine and Poor Efficacy Rates:

Klock, L.E., et al. “Failure of rubella herd immunity during an epidemic.” New England Journal of Medicine 1973; 288(2):69-72.

Allan, B. “Rubella immunisation.” Australian Journal of Medical Technology 1973; 4:26-27. Lawless, M., et al. “Rubella susceptibility in sixth-graders.” Pediatrics (June 1980); 65:1086-1089. Bart, K.J., et al. “Universal immunization to interrupt rubella.” Review of Infectious Diseases 1985;

7(1):S177-184. Crowder, M., et al. “Rubella susceptibility in young women of rural East Texas: 1980 and 1985.”

Texas Medicine 1987; 83:43-47. Fulginiti, V. “Controversies in current immunization policy and practices.” Current Problems in

Pediatrics 1976; 6:14. Herrmann, K.L., et al. “Rubella antibody persistence after immunization.” Journal of the America

Medical Association 1982; 247(2):193-196.

45

Tingle, A.J., et al. “Failed rubella immunization in adults: association with immunologic and virological abnormalities.” Journal of Infectious Diseases 1985; 151(2):330-336.

The Rubella Vaccine Altered the Epidemiology of the Disease(It Shifted Cases to High-Risk Groups):

Cherry, J.D. “The ‘new’ epidemiology of measles and rubella.” Hospital Practice (July 1980), p. 55. CDC. “Rubella and congenital rubella syndrome—United States, 1985-1988. MMWR 1989;

38:173-178. CDC. “Current trends increase in rubella and congenital rubella syndrome —United States, 1988-

1990.” MMWR Weekly (February 15, 1991); 40(6):93-99.

Doctors Refuse the Rubella Vaccine:

Mendelsohn, R. “Rubella shots for hospital employees.” The Doctor’s People: A Medical Newsletter for Consumers (Evanston, IL, August 1991):1-2.

Polk, B.F., et al. “An outbreak of rubella among hospital personnel.” New England Journal of Medicine 1980;303:541-545.

Orenstein, W.A., et al. “Rubella vaccine and susceptible hospital employees: poor physician participation.” Journal of the American Medical Association (February 20, 1981); 245(7):711-713.

Sacks, J.J., et al. “Employee rubella screening program.” Journal of the American Medical Association 1983; 249:2675-2678.

Miscellaneous Vaccine Studies

Vaccines and Unexplained Diseases:

Hiner, E E, Frasch, C E, "Spectrum of Disease Due to Haemophilus Influenza Type B Occurring in Vaccinated Children", J Infect Disorder, 1988 Aug; 158(2): 343-348.

Olin P, Romanus, V, Storsaeter, J, "Invasive Bacterial Infections During an Efficiacy Trial of Acellular Pertussis Vaccines --Implications For Future Surveilance In Pertussis Vaccine Programmes", Tokai J Exp Clin Med, 1988; 13 Suppl: 143-144.

Storsaeter, J, et al, "Mortality and Morbidity From Invasive Bacterial Infections During a Clinical Trial of Acellular Pertussis Vaccines in Sweden", Pediatr Infect Disorder J, 1988 Sept; 7(9):637-645.

Vadheim, CM, et al, "Effectiveness and Safety of an Haemophilus Influenzae type b Conjugate Vaccine (PRP-T) in Young Infants. Kaiser-UCLA Vaccine Study Group," Pediartics, 1993 Aug; 92(2):272-279. [The vaccines caused fevers, irritability, crying, and seizures, but were declared to be "safe and ... effective ... ".]

Stickl, H, "Estimation of Vaccination Damage", Med Welt, Oct 14, 1972, 23:1495-1497. Waters, VV, et al, "Risk Factors for Measles in a Vaccinated Population", JAMA, Mar 27, 1991,

265(12): 1527. Stickl, H, "Iatrogenic Immuno-suppression as a Result of Vaccination", Fortschr Med, Mar 5, 1981,

99(9);289-292.

Vaccines Cause the "Prevented" Disease :

Nkowane, et al, "Vaccine-Associated Paralytic Poliomyelitis, US 1973 through 1984, JAMA, 1987, Vol 257:1335-1340.

Quast, et al, "Vaccine Induced Mumps-like Diseases", nd, Int Symp on Immun, Development Bio Stand, Vol 43, p269-272.

Green, C et al, "A Case of Hepatitis Related to Etretinate Therapy and Hepatitis B Vaccine", Dermatologica, 1991, 182(2):119-120.

Shasby, DM, et al, "Epidemic Measles in Highly Vaccinated Population", NEJM, Mar 1977, 296(11): 585-589.

Tesovic, G et al, "Aseptic Meningitis after Measles, Mumps and Rubella Vaccine", Lancet, Jun 12, 1993, 341(8859):1541.

46

Johnson, RH, et al, "Nosocomial Vaccinia Infection", West J Med, Oct 1976, 125(4):266-270. Malengreau, M, "Reappearance of Post-Vaccination Infection of Measles, Rubella, and Mumps.

Should Adolescents be re-vaccinated?" Pedaitric, 1992;47(9):597-601 (25 ref) Basa, SN, "Paralytic Poliomyelitis Following Inoculation With Combined DTP Prophylactic. A

review of Sixteen cases with Special Reference to Immunization Schedules in Infancy", J Indian Med Assoc, Feb 1, 1973, 60:97-99.

Landrigan, PJ et al, "Measles in Previously Vaccinated Children in Illinois", Ill Med J, Arp 1974, 141:367-372.

NA, "Vaccine-Associated Poliomyelitis", Med J Aust, Oct 1973, 2:795-796.

Vaccine Failures:

Hardy, GE, Jr, et al, "The Failure of a School Immunization Campaign to Terminate an Urban Epidemic of Measles," Amer J Epidem, Mar 1970; 91:286-293.

Cherry, JD, et al, "A Clinical and Serologic Study of 103 Children With Measles Vaccine Failure", J Pediatr, May 1973; 82:801-808.

Jilg, W, et al, "Inoculation Failure Following Hepatitis B Vaccination", Dtsch Med wochenschr, 1990 Oct 12; 115(41):1514-1548.

Plotkin, SA, "Failures of Protection by Measles Vaccine," J Pediatr, May 1973; 82:798-801. Bolotovskii, V, et al, "Measles Incidence Among Children Properly Vaccinated Against This

Infection", ZH Mikrobiol Epidemiol Immunobiol, 1974; 00(5):32-35. Landrigan, PJ, et al, "Measles in Previously Vaccinated Children in Illinois", Ill Med J, Apr 1974;

141:367-372. Strebel, P et al, "An Outbreak of Whooping Cough in a Highly Vaccinated Urban Community", J

Trop Pediatr, Mar 1991, 37(2): 71-76. Forrest, JM, et al, "Failure of Rubella Vaccination to Prevent Congenital Rubella,"Med J Aust,

1977 Jan 15; 1(3): 77. Jilg, W, "Unsuccessful Vaccination against Hepatitis B", Dtsch Med Wochenschr, Nov 16, 1990,

115(46):1773. Coles, FB, et al, "An Outbreak of Influenza A (H3N2) in a Well-Immunized Nursing home

Population," J Am ger Sociologist, Jun 1992, 40(6):589-592. Jilg, W, et al, "Inoculation Failure following Hepatitis B Vaccination," Dtsch Med Wochenschr, Oct

12, 1990, 115(41):1545-1548. Hartmann, G et al, "Unsuccessful Inoculation against Hepatitis B," Dtsch Med Wochenschr, May

17, 1991, 116(20): 797. Buddle, BM et al, "Contagious Ecthyma Virus-Vaccination Failures", Am J Vet Research, Feb

1984, 45(2):263-266. Mathias, R G, "Whooping Cough In Spite of Immunization", Can J Pub Health, 1978 Mar/Apr;

69(2):130-132. Osterholm, MT, et al, "Lack of Efficacy of Haemophilus b Polysacharide Vaccine in Minnesota",

JAMA, 1988 Sept 9; 260(10:1423-1428. Johnson, RH, et al, "Nosocomial Vaccinia Infection", West J Med, Oct 1976, 125(4):266-270.

Vaccines Causing Another Vaccinal Disease:

Basa, SN, "Paralytic Poliomyelitis Following Inoculation With Combined DTP Prophylactic. A review of Sixteen cases with Special Reference to Immunization Schedules in Infancy", J Indian Med Assoc, Feb 1, 1973, 60:97-99.

Pathel, JC, et al, "Tetanus Following Vaccination Against Small-pox", J Pediatr, Jul 1960; 27:251-263.

Favez, G, "Tuberculous Superinfection Following a Smallpox Re-Vaccination", Praxis, July 21, 1960; 49:698-699.

Quast, Ute, and Hennessen, "Vaccine-Induced Mumps-like Diseases", Intern Symp on Immunizations , Development Bio Stand, Vol 43, p 269-272.

Forrest, J M, et al, "Clinical Rubella Eleven months after Vaccination," Lancet, Aug 26, 1972, 2:399-400.

Dittman, S, "Atypical Measles after Vaccination", Beitr Hyg Epidemiol, 19891, 25:1-274 (939 ref) Sen S, et al, "Poliomyelitis in Vaccinated Children", Indian Pediatr, May 1989, 26(5): 423-429. Arya, SC, "Putative Failure of Recombinant DNA Hepatitis B Vaccines", Vaccine, Apr 1989, 7(2):

164-165. Lawrence, R et al, "The Risk of Zoster after Varicella Vaccination in Children with Leukemia",

NEJM, Mar 3, 1988, 318(9): 543-548.

47

Vaccines and Death:

Na, "DPT Vaccination and Sudden Infant Death - Tennessee, US Dept HEW, MMWR Report, Mar 23, 1979, vol 28(11): 132.

Arevalo, "Vaccinia Necrosum. Report on a Fatal Case", Bol Ofoc Sanit Panamer, Aug 1967, 63:106-110.

Connolly, J H, Dick, G W, Field, CM, "A Case of Fatal Progressive Vaccinia", Brit Med Jour, 12 May 1962; 5288:1315-1317.

Aragona, F, "Fatal Acute Adrenal Insufficiency Caused by Bilateral Apoplexy of the Adrenal Glands (WFS) following Anti-poliomyelitis Vaccination", Minerva Medicolegale, Aug 1960; 80:167-173.

Moblus, G et al, "Pathological-Anatomical Findings in Cases of Death Following Poliomyelitis and DPT Vaccination", Dtsch Gesundheitsw, Jul 20, 1972, 27:1382-1386.

NA, "Immunizations and Cot Deaths", Lancet, Sept 25, 1982, np. Goetzeler, A, "Fatal Encephalitis after Poliomyelitis Vaccination", 22 Jun 1961, Muenchen Med

Wschr, 102:1419-1422. Fulginiti, V, "Sudden Infant Death Syndrome, Diphtheria-Tetanus Toxoid-Pertussis Vaccination

and Visits to the Doctor: Chance Association or Cause and Effect?", Pediatr Infect Disorder, Jan-Feb 1983, 2(1): 7-11.

Baraff, LJ, et al, "Possible Temporal Association Between Diphtheria-tetanus toxoid-Pertussis Vaccination and Sudden Infant Death Syndrome", Pediatr Infect Disorder, Jan-Feb 1983, 2(1): 5-6.

Reynolds, E, "Fatal Outcome of a Case of Eczema Vaccinatum", Lancet, 24 Sept 1960, 2:684-686. Apostolov. et al, "Death of an Infant in Hyperthermia After Vaccination", J Clin Path, Mar 1961,

14:196-197. Bouvier-Colle, MH, "Sex-Specific Differences in Mortality After High-Titre Measles Vaccination",

Rev Epidemiol Sante Publique, 1995; 43(1): 97. Stewart GT, "Deaths of infants after triple vaccine.", Lancet 1979 Aug 18;2(8138):354-355. Flahault A, "Sudden infant death syndrome and diphtheria/tetanus toxoid/pertussis/poliomyelitis

immunisation.", Lancet 1988 Mar 12;1(8585):582-583. Larbre, F et al, "Fatal Acute Myocarditis After Smallpox Vaccination", Pediatrie, Apr-May 1966,

21:345-350. Mortimer EA Jr, "DTP and SIDS: when data differ", Am J Public Health 1987 Aug; 77(8):925-926.

Vaccines and Metabolism:

Deutsch J, " [Temperature changes after triple-immunization in infant age]," Padiatr Grenzgeb 1976;15(1):3-6. [Article in German]

NA, "[Temperature changes after triple immunization in childhood]," Padiatr Grenzgeb 1976;15(1):7-10. [Article in German]

[Considering that the thyroid controls our Basal Metabolism, it would appear that vaccines altered (depressed) thryoid activity.]

Vaccines Altering Resistance to Disease:

Burmistrova AL, "[Change in the non-specific resistance of the body to influenza and acute respiratory diseases following immunization diphtheria-tetanus vaccine]," Zh Mikrobiol Epidemiol Immunobiol 1976; (3):89-91. [Article in Russian]

Vaccines and Kidney Disorders:

Jacquot, C et al, "Renal Risk in Vaccination", Nouv Presse Med, Nov 6, 1982, 11(44):3237-3238. Giudicelli, et al, "Renal Risk in Vaccination", Presse Med, Jun 11, 1982, 12(25):1587-1590. Tan, SY, et al, "Vaccine Related Glomerulonephritis", BMJ, Jan 23, 1993, 306(6872):248. Pillai, JJ, et al, "Renal Involvement in Association with Post-vaccination Varicella", Clin Infect

Disorder, Dec 1993, 17(6): 1079-1080. Eisinger, AJ et al, "Acute Renal Failure after TAB and Cholera Vaccination", B Med J, Feb 10,

1979, 1(6160):381-382. Silina, ZM, et al, "Causes of Postvaccinal Complications in the Kidneys in Young Infants",

Pediatria, Dec 1978, (12):59-61. Na, "Albuminurias", Concours Med, Mar 1964, 85:5095-5098. [vaccination adverse reactions] Oyrl, A, et al, "Can Vaccinations Harm the Kidney?", Clin Nephrol, 1975, 3(5):204-205.

48

Mel'man Nia, "[Renal lesions after use of vaccines and sera]." Vrach Delo 1978 Oct;(10):67-9, [Article in Russian]

Silina ZM, Galaktionova TIa, Shabunina NR, "[Causes of postvaccinal complications in the kidneys in young infants]." Pediatriia 1978 Dec;(12):59-61, [Article in Russian]

Silina EM, et al, "[Some diseases of the kidneys in children during the 1st year of life, following primary smallpox vaccination and administration of pertusis-diphtheria-tetanus vaccine]." Vopr Okhr Materin Det 1968 Mar; 13(3):79-80, [Article in Russian]

Vaccines and Skin Disorders:

Illingsworth R, "Skin rashes after triple vaccine," Arch Dis Child 1987 Sep; 62(9):979. Lupton GP, "Discoid lupus erythematosus occurring in a smallpox vaccination scar," J Am Acad

Dermatol, 1987 Oct; 17(4):688-690. Kompier, A J, "Some Skin Diseases caused by Vaccinia Virus [Smallpox]," Ned Milt Geneesk T,

15:149-157, May 1962. Weber, G et al, "Skin Lesions Following Vaccinations," Deutsch Med Wschr, 88:1878-1886, S7

Sept 1963. Copeman, P W, "Skin Complications of Smallpox Vaccination," Practitioner, 197:793-800, Dec

1966. Denning, DW, et al, "Skin Rashes After Triple Vaccine," Arch Disorder Child, May 1987, 62(5):

510-511.

Vaccines and Abcesses:

Sterler, HC, et al, "Outbreaks of Group A Steptococcal Abcesses Following DTP Vaccination", Pediatrics, Feb 1985, 75(2):299-303.

DiPiramo, D, et al, "Abcess Formation at the Site of Inoculation of Calmette-Guerin Bacillus (BCG)," Riv Med Aeronaut Spaz, Jul-Dec 1981, 46(3-4):190-199.

Vaccines and Shock:

Caileba, A et al, "Shock associated with Disseminated Intravascular Coagulation Syndrome following Injection of DT.TAB Vaccine, Prese Med, Sept 15, 1984, 13(3):1900.

Other Citations:

Pathel, JC, et al, "Tetanus Following Vaccination Against Small-pox", J Pediatr, Jul 1960; 27:251-263.

Favez, G, "Tuberculous Superinfection Following a Smallpox Re-Vaccination", Praxis, July 21, 1960; 49:698-699.

Bonifacio, A et al, "Traffic Accidents as an expression of "Iatrogenic damage", Minerva Med, Feb 24, 1971, 62:735-740. [But officer I was just vaccinated!]

Baker, J et al, "Accidental Vaccinia: Primary Inoculation of a Scrotum", Clin Pediatr (Phila), Apr 1972, 11:244-245.

Edwards, K, "Danger of Sunburn Following Vaccination", Papua New Guinea Med J, Dec 1977, 20(4):203.

Stroder, J, "Incorrect Therapy in Children", Folia Clin Int (Barc), Feb 1966, 16:82-90. [Agreed.] Wehrle PF, "Injury associated with the use of vaccines," Clin Ther 1985;7(3):282-284. Alberts ME, "When and where will it stop", Iowa Med 1986 Sep; 76(9):424. [When!] Breiman RF, Zanca JA, "Of floors and ceilings--defining, assuring, and communicating vaccine

safety", Am J Public Health 1997 Dec;87(12):1919-1920. Stewart, AM, et al, "Aetiology of Childhood Leukaemia", Lancet, 16 Oct, 1965, 2:789-790. Nelson, ST, "John Hutchinson On Vaccination Syphilis (Hutchinson, J)", Arch Derm, (Chic), May

1969, 99:529-535. Mather, C, "Cotton Mather Anguishes Over the Consequences of His Son’s Inoculation Against

Smallpox", Pediatrics, May 1974; 53:756. Thoman M, "The Toxic Shot Syndrome", Vet Hum Toxicol, Apr 1986, 28(2):163-166. [Animals are

not exempt from vaccination damage either!]

49

Johnson, RH, et al, "Nosocomial Vaccinia Infection", West J Med, Oct 1976, 125(4):266-270. [Nosocomial means a disease acquired in a doctor’s office or hospital.]

Heed, JR, "Human Immunization With Rabies Vaccine in Suckling Mice Brain," Salud Publica, May-Jun 1974, 16(3): 469-480.

Tesovic, G et al, "Aseptic Meningitis after Measles, Mumps and Rubella Vaccine", Lancet, Jun 12, 1993, 341(8859):1541. [AM has same symptoms as poliomyelitis!]

Buddle, BM et al, "Contagious Ecthyma Virus-Vaccination Failures", Am J Vet Research, Feb 1984, 45(2):263-266.

Freter, R et al, "Oral Immunization And Production of Coproantibody in Human Volunteers", J Immunol, Dec 1963, 91:724-729. [copro = Feces]

NA, "Vaccination, For and Against", 1964, Belg T Geneesk, 20:125-130. [Is it for or against?] Sahadevan, MG et al, "Post-vaccinal Myelitis", J Indian Med Ass, Feb 16, 1966, 46:205-206. Castan, P et al, "Coma Revealing an acute Leukosis in a child, 15 days after an Oral Anti-

poliomyelitis Vaccination," Acta Neurol Bekg, May 1965, 65:349-367. [Coma from vaccines!] Stickl, H, et al, "Purulent [pus] meningitides Following Smallpox Vaccination. On the Problem of

Post-Vaccinal Decrease of Resistance", Deutsch Med Wschr, Jul 22, 1966, 91:1307-1310. Haas, R, et al, "Studies on the Occurrence of Viremia Following Oral Poliomyelitis Vaccination with

Sabin Type I Strain LSC2ab", Deutsch Med Wschr, Mar 4, 1968, 91:385-389. Converse, J L, et al, "Control of Tissue Reactions in monkeys vaccinated with Viable Coccidioides

immitis by prevaccination with killed Coccidioides immitis", J Bact, Sept 1965, 90:783-788. Motelunas, LI et al, "The Potential Epidemiological Hazard of Parental Transmission of Epidemic

Hepatitis as the Result of Vaccination," Zh Mikrobiol, Nov 1965, 42:105-108. Krudusz, J, "Effect of Vaccinotherapy on the Sedimentation Rate and On the Hematocrit", Klin

Oczna, 1967, 37:191-195. Pop, A, "Production of Laboratory Animals for the Production of Serums and Vaccines," Arch

Roum Path Exp Mocrobiol, 1967, 23:423-430. [Animal research for vaccine production!] Espmark, A, "The Composition of Vaccines With Reference to Potentially Injurious Allergens",

Lakartidningen, Nov 3, 1965, 62:3662-3667. DeRenzi, S, et al, "Damage Caused by Vaccine Therapy and Serotherapy", Clin Ter, Sept 30,

1966, 38:497-500. Lewis, J, "Iatrogenic Malaria," New Zeal Med J, Feb 1970, 71:88-89. [Malaria caused by the

doctor!] Prakken, JR, "Syphilization", Nederl T Geneesk, Jun 13, 1970, 114:1019-1023. Damert, C et al, "Hygenical and Bacteriological Inspection of the Execution of Vaccination," Z

Gesamite Hyg, Jul 1974, 20(7):439-442. Na, "Sibling Accidentally Vaccinates other Following Inoculation", Can Med Assoc J, Aug 4,

1973, 109:237. Opitz, B et al, "Prevention of Iatrogenic Infections Following Vaccination", Dtsch Gesundheltsw,

Jun 15, 1972, 27:1131-1136. Raff, MJ, "Progressive Vaccinia (Vaccinia Gangrenosum)", J Ky Med Assoc, Feb 1973, 71:92-95. Hanissian, AS et al, "Vasculitis and Myositis Secondary to Rubella Vaccination", Arch Neurol,

Mar 1973, 28:202-204. Cho, CT, et al, "Panencephalitis Following Measles Vaccination", JAMA, May 28, 1973,

224:1299. Rubin, R H, et al, "Adverse Reactions to Duck Embryo Rabies Vaccine. Range and Incidence,"

Ann Intern Med, May 1973, 78:643-649. Gunderman, JR, "Guillain-Barre Syndrome. Occurrence Following Combined Mumps-Rubella

Vaccine", Am J Disorder Child, Jun 1973, 125:834-835. [GBS is paralysis!] Hale, MS et al, "Carpal Tunnel Syndrome Associated With Rubella Immunization", Am J Phys

Med, Aug 1973, 52:189-194. Provost, A et al, "Inopportune Cattle Mucosal Diseases Associated With Rinderpest Vaccine", Bull

Epizoot Afr, Dec 1972, 20:265-267. Budal, J, "Hazards of Prophylactic Vaccination," Orv Hetil, Sept 10, 1972, 113:2237-2240. Levenbuk, IS, et al, "A Morphological Study of the Harmlessness of Live Dysentery Vaccines

From Streptomycin Dependent Mutants of Sh. Flexnert", ZH Mikrobiol Epidemiol Immunobiol, Feb 1972, 49:18-22.

Arnold, H, "Our Vaccination Service is Sick", Oeff Egsundheitswes, Feb 1974, 36:133-134. Spless, H, "Sterility of Vaccination Guns", Dtsch Med Wochenschr, Jun 27, 1975, 100(26):1445-

1446. [Make sure the gun is sterile, because what is inside it isn’t.] Redey, B, "Self-Experiments with the Ingestion of Various Bacteria", Acta Microbiol Acad Sci

Hung, 1974, 21(1-2):45-62. Webster, AC, "The Adverse Effect of Environment on the Response to Distemper Vaccination",

Aust Vet J, Oct 1975, 51(10): 488-490. NA, "Vaccines Made From House-Dust Mites", Drug Ther Bull, Apr 23, 1976, 14(9):35-36. [Sic!]

50

Levaditi, JC et al, "Local Tolerance of Vaccines Adsorbed on Immuno-Stimulating Substances", Sem Hop Ther, Feb 1975, 51(2):117-118.

Miller, Ta, "The Possibilities for Application of the Canine Hookworm Vaccine Technology to the Prevention and Control of Hookworm Infection and Disease in Man", In: Nuclear Techniques in Helminthology Research, Vienna, International Atomic Energy Agency, 1973.

Borsche, A, "What are the Hazards of Vaccinations in Childhood?" ZFA, May 10, 1976, 52(13):666-674.

Starke, G, et al, "Requirements for the Control of a Dog Kidney Cell-adapted Live Mumps Virus Vaccine", J Biol Stand, Apr 1974, 2(2):143-150. [DKC = Dog Kidney Cells]

Garlick, P et al, "Stimulation of Protein Synthesis and Breakdown By Vaccination", Br Med J, Jul 26, 1980, 281(6235):263-265.

Weissmann, G, "In Quest of Fleck: Science From the Holocaust", Hosp Pract, Oct 1980, 15(10):48-49.52, 54-55 passim.

Williams, Go, "Vaccines in Older Patients: Combating the Risk of Mortality", Geriatrics, Nov 1980, 35(11):55-57, 63-64.

Sun, M, "Compensation for Victims of Vaccines", np, Feb 27, 1981, 211(4485):906-908. Hillary, IB, et al, "Persistence of antibody 10 years after Vaccination with Wistar RA 27/3 Strain of

Live Attenuated Rubella Vaccine", Br Med J, Jun 28, 1980, 280(6231):1580-1581. [RA 27/3 refers to an aborted fetus.]

Frerichs, GN et al, "Estimation of Residual Free Formaldehyde in Biological Products", J Biol Stand 1980; 8(2):139-144. [Formaldehyde is a carcinogen.]

Ambs, E et al, "Tuberculous Abcess of the Upper Arm With Regional Lymphadenitis as a Consequence of Injection in Two Siblings", Med Klin, July 7, 1967, 62:1050-1054.

Davis, LE, "Communicating Hydrocephalus in New born Hamsters and Cats Following Vaccinia Virus infection", J Neurosurg, Jun 1981, 54(6):767-772. [Hydrocephalus is similar to brain swelling.]

Simon, J et al, "A new Model of Multiple Sclerosis. Experimental Vaccinia Infection in the Monkey", Forschr Med, Nov 6, 1980, 98(41):1607-1611. [Links between vaccines and MS.]

Barrie, H, "Campaign of Terror", AM J Disorder Child, Sept 1983, 137(9):922-923. [Qui tu - Vaccination - Et Brutus?]

Stickl, H, "Discussion on the Most Favorable Age For Primary Smallpox Vaccination of Children", Monatsschr Kinderheilkd, Sept 1970, 118:541-544. [Answer - none!]

Daugaard, J, "Adverse Effects of Vaccination. The Liability of Physicians and The objective Liability," Nord Med, Jun 1972, 87:183-184.

Conteras Poza L, et al, "An Unusual Accident During Smallpox Vaccination: Intramuscular Injection of the Lymph Vaccine", Rev Sanid hig Publica (Madr) Oct 1971, 45:1017-1022. [I thought that vaccines were supposed to be given IM.]

Nosov, SD, et al, "Systematization of Reactions Developing After Prophylactic Vaccination", Pediatria, Feb 1972, 51:10-15.

Remsey, "Iatrogenic [Doctor -caused] Disease Caused by Vaccination", Orv Hetil, Sept 1971, 112:2245.

Stickl, H, "Estimation of Vaccination Damage", Med Welt, Oct 14, 1972, 23:1495-1497. Millichap JG, et al, "Etiology and treatment of infantile spasms: current concepts, including the

role of DPT immunization," Acta Paediatr Jpn 1987 Feb; 29(1):54-60. Mason, MM et al, "Toxicology and Carcinogenesis of Various Chemicals Used in the Preparation

of Vaccines", np, Jun 1971, 4:185-204. Michiels, J, "Harmful Effects of Common Drugs on the Vital Apparatus. Agents of Immunity." Bull

Sociologist Beige Ophtalmol, 1972, 160:467-483. Knudsen, Rc, et al, "Difference in the Protective Immunity of the tongue and feet of Guinea Pigs

Vaccinated with Foot-and-Mouth Disease Virus Type A12 Following intradermolingual and Footpad [foot and mouth]Challenge", Vet Microbiol, May 1982, 7(2):97-107.

Elliman, D, "Vaccination and Professional Confusion", Br Med J, Sept 15, 1990, 301(675):551. NA, "Risk Language Preferred By Mothers in Considering a Hypothetical New Vaccine For Their

Children", 1991, np. Levine, MM, "Non-target Effects of Live Vaccines: Myth, Reality and Demagoguery," Development

Biol Stand, 1995, 84:33-38. Stickl, H, "No Negligence in Preventive Vaccinations", Fortschr Med, July 20, 1989, 107(21):14-

15. Donaldson, AI, et al, "Transmission of Foot-and-mouth Disease by Vaccinated Cattle Following

Natural Challenge", Research Vet Sci, Jan 1989, 46(1):9-14. Spier, RE, "Democratic Governments and Vaccines", Vaccine, Nov 1994, 12(15):1363. Cichutek, K, Nucleic Acid Immunizations", Vaccine, Dec 1994, 12(16):1520-1525 (23 ref). [Gene

therapy could make autoimmune diseases increase.] Alexander, NJ, et al, "Contraceptive Vaccine Development", Reprod Fertil Development, 1994,

6(3):273-280.

51

Allen, JM, "Over-the-counter Sale of Drugs and Vaccines, J AM Vet Med Assoc, Feb 1, 1995, 206(3):286.

Harte, PG et al, "Failure of Malaria Vaccine in Mice Born to Immune Mothers", Clin Exp Immunol, Sept 1982 49(3):509-516.

Editorial, "Are We Vaccinating without Reason?", Lakartidningen, Nov 27, 1974, 71(48):4915. Na, "The Hen’s Egg versus the Horse’s Brain: ..." 1988, np, Bonard, EC, "Is Vaccination Still Necessary?" , Rev Med Suisse Romande, Oct 1987,

107(10):781-782. Forrester, HL, et al, "Inefficacy of Pneumococcal vaccine in a High Risk Population," Am J Med,

Sept 1987, 83(3): 425-430. NA, "Protection for AIDS Vaccine Suits", NJMed, May 1989, 86(5):338. NA, "AIDS Vaccines: Is Optimism Justified? Fortschr Med, Jul 20, 1989, 107(21):13. Perez Diaz R, et al, "[Post-vaccinal Pericarditis. Report of 2 Cases]", Rev Cuba Med, 1:49-54, Jul-

Aug 1962. Larbre, F et al, "Fatal Acute Myocarditis After Smallpox Vaccination", Pediatrie, Apr-May 1966,

21:345-350.

Lungs:

• Chudwin, DS, et al, "Lung Involvement in Progressive Vaccinia", West J Med, May 1981, 134(5):446-448.

Liver:

• Lilic, D, et al, "Liver Dysfunction and DNA Antibodies after Hepatitis B Vaccination", Lancet, Nov 5, 1994, 344(8932):1292-1293.

Eyes:

• Goldman, A, "Occular Vaccinia: A Case Report and Review of Treatment," Med J Aust, Nov 30, 1968, 2:921-922.

• Rennie, AG et al, "Occular Vaccinia," Lancet, Aug 3, 1974, 2:273-275.

Vaccinations Don’t Work:

• Gilchrist, A, "To Vaccinate is Not Always to Immunize", Med J Aust, May 6, 1991, 154(9):638.

• Daniel, J C, "The Polio Paradox, One of the Two Polio Vaccines Has Been Largely Abandoned in the US; The other is the Leading Cause of the Disease", Science, April 1986, p 37-39.

52

A PARTIAL LIST OF MEDICAL JOURNAL ARTICLES · Web viewA PARTIAL LIST OF MEDICAL JOURNAL ARTICLES and articles from other scientific journals DEALING WITH THE DANGER OF VACCINES Hronological

Documents